Skip to main content Accessibility help
×
Hostname: page-component-54dcc4c588-b5cpw Total loading time: 0 Render date: 2025-10-13T22:25:51.988Z Has data issue: false hasContentIssue false

Part III - Health, Workforce, and Innovation: The Investments Required for a Healthy Lifespan

Published online by Cambridge University Press:  13 May 2025

Anne L. Alstott
Affiliation:
Yale University, Connecticut
Abbe R. Gluck
Affiliation:
Yale University, Connecticut
Eugene Rusyn
Affiliation:
Yale University, Connecticut

Summary

Information

Type
Chapter
Information
Law and the 100-Year Life
Transforming Our Institutions for a Longer Lifespan
, pp. 171 - 242
Publisher: Cambridge University Press
Print publication year: 2025
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - NC
This content is Open Access and distributed under the terms of the Creative Commons Attribution licence CC-BY-NC 4.0 https://creativecommons.org/cclicenses/

Part III Health, Workforce, and Innovation: The Investments Required for a Healthy Lifespan

13 The 100-Year-Old American and Our Health System

There is a consensus among researchers that the US health system is inadequate when it comes to ensuring the health of older adults. Indeed, while many Americans live longer today than several decades ago, they often live those “extra” years in poor health.Footnote 1 In fact, Americans are generally less healthy than their counterparts in other high-income nations. For example, they are more likely to experience multiple chronic conditions and have far higher rates of obesity. And this is especially true for certain populations, most notably racial minorities and low-income individuals, who still suffer from structural racism and intergroup disparities in health.Footnote 2 This is ironic given that the US spends 4.3 trillion dollars a year on health care, much more than peer countries that enjoy far better health-related outcomes.Footnote 3

In this chapter, we provide some insights into this conundrum, which has become acute due to the aging of the American population. Divided into three sections, this chapter will focus on offering structural interventions and their attendant benefits. Section 13.1 identifies the main goal of a successful health system in the twenty-first century – creating optimal health for a longer life – and the primary conditions needed for accomplishing this goal. These include a public health approach that zeroes in on ex-ante prevention, not just ex-post treatment, and an expanded geriatric healthcare workforce to meet the demands of an aging population. Section 13.2 considers the question of how to finance health care for the older population given the challenges posed by the rise in life expectancy. Section 13.3 imagines the unique opportunities – the so-called third demographic dividend – that may arise if Americans could live long, healthy lives.

13.I The Goal: Optimal Health for a Longer Life

One important goal of a successful healthcare system in the twenty-first century is to prolong health span – the average length of healthy lifeFootnote 4 – so that people will be able to live meaningful and purposeful lives well into their nineties and beyond. Achieving this goal is no doubt a difficult task, but it is possible.Footnote 5 It requires taking a wide array of measures across several healthcare dimensions, such as physician compensation, insurance, and health professionals’ training, as well as focusing on broader issues, including revising the public health system, nutrition, and affordable housing. Space does not permit a comprehensive analysis of all of the steps required to accomplish this goal. Instead, this chapter focuses on two exigent issues: (1) the particular importance, in the context of health span, of investing in public health systems; and (2) reshaping geriatric care. We discuss each of these issues in turn.

13.1.1 Rebalancing and Aligning Public Health and Healthcare Systems

Promoting older adults’ health requires taking measures during the decades that precede old age. Indeed, as one of us has noted elsewhere, “people who arrive at old age healthy are positioned to remain healthier into the oldest ages.”Footnote 6 To translate such a “life course” perspective into a practical framework, we need to focus not only on the delivery of health care but also on the conditions necessary for people to be healthy. This means, for example, guaranteeing that all Americans can access healthy food, participate in physical activities, and have opportunities for social engagement. In other words, we need to build a social infrastructure that makes healthy choices easy choices – an approach that has traditionally been associated with a public health framework. To do this, we need to reinvest in the US public health system and mandate it to increase health span for all.

The public health system is responsible for the actions “we, as a society, do collectively to assure the conditions in which people can be healthy,”Footnote 7 with particular focus on preventing disease, disability, and injury and on improving the health of the population. It accomplishes this through the work of the Centers for Disease Control and Prevention (CDC) and 3,000 state, local, tribal, and territorial departments, through actions ranging from surveillance to assess health and its drivers to recommending and implementing programs, policies, and practices for improved population health based on scientific evidence.

Unfortunately, as the COVID-19 pandemic made evident, the US health system has failed to fully realize a public health infrastructure. One primary reason is that the field of public health has been disinvested over the past sixty years. Responsible for 70 percent of a population’s health,Footnote 8 it receives less than 3 percent of US health dollars. In the US, the healthcare sector has traditionally focused on ameliorating or curing conditions. Despite some progress in recent years, most notably as a result of the passage of the Affordable Care Act (ACA), policymakers have not given enough attention to the role of individualized prevention strategies in promoting health. At the same time, the complementary population-focused perspective of the public health system is critical for success.

In recent decades, the US has only decreased the share of its public health spending vis-à-vis total health spending. One reason has to do with the way federal legislation is scored for budget purposes; it’s hard to quantify upfront, as federal law requires, short-term returns on investments in public health infrastructure. Relatedly, the longer timeline for returns on investments in public health often does not sync with election cycles and political arguments. Nevertheless, as a number of researchers have shown, our traditional focus on individualized treatment is often less cost-effective than population-based prevention and health promotion, and individualized care is not sufficient to accomplish prevention.Footnote 9 Both are needed, in the right balance.

The US approach is exceptional from a comparative perspective. On average, the Organization for Economic Co-operation and Development (OECD) member countries spend more than double on non-healthcare social investments than they do on health care.Footnote 10 And the data unequivocally indicate that the approach taken by other OECD members leads to far better outcomes at lower cost: The US obesity rate is almost double the OECD average and the percentage of people experiencing chronic conditions is also much higher in the US than in other countries. Against this backdrop, the US National Academy of Medicine’s recently released “Global Roadmap for Healthy Longevity” called for significantly increased investment in public health system-led prevention.Footnote 11

Promoting a public health perspective has the potential to benefit everyone, but it is particularly important for older adults, who are at greater risk of experiencing chronic conditions such as cancer, hypertension, diabetes, and Alzheimer’s. In recent years, there has been growing evidence showing that, despite common beliefs, the emergence of chronic conditions in older ages is not inevitable; rather, it may depend on an array of individual, social, and environmental factors, and reducing such exposures is effective prevention.Footnote 12 Thus, we need the public health system to deliver programs for older adults, as well as middle-aged, to prevent heart disease, strokes, falls, diabetes, cognitive impairment, disability and frailty, as well as loneliness. Specific interventions include investing in a range of community-based public health programs aimed at increasing physical activity, eating healthy foods, and not smoking, as well as increasing social connection and engagement. For example, programs involving food labeling and public service announcements have been proven useful in encouraging people to consume healthier products.Footnote 13 Allowing older adults to buy affordable bags of vegetables, fruits, and protein from accessible stores serves as another example for an intervention in the area of nutrition. Other public health programs may include, perhaps more ambitiously, controlling air and water pollution and toxins in our environment that both damage children’s brains and increase dementia risk.

Loneliness is epidemic among both old and young. The US Surgeon General’s report in 2023 advocates public health systems and offices for the aging working together to build expanded opportunities for social connection and engagement in communities to help decrease loneliness.Footnote 14 For example, group exercise programs designed for older adults with different health statuses may foster connectivity and increase strength, balance, and fitness among participants.

There is strong evidence that a diversity of population-based programs to increase a community’s physical activity levels, to make healthy foods accessible and affordable, and to teach people to prepare nutritious foods are important components of preventing obesity and diabetes, and lowering the risks of these diseases reduces risks of subsequent cardiovascular disease.Footnote 15 Moreover, in an oft-cited study conducted in Finland, researchers found that elderly people who were at risk of dementia and had received a two-year, “multidomain” preventive intervention (focusing on dietary changes, physical activity, and cognitive training) experienced a significant improvement in cognitive functions in comparison to their counterparts who only received general health recommendations.Footnote 16 This finding is promising in its own right, but it is especially important given that existing medical treatment for Alzheimer’s disease, the most common type of dementia, has yet to prove meaningful, long-term efficacy.Footnote 17

Given the promise of preventive care, why haven’t we put more emphasis on public health interventions? One explanation found in the literature has to do with the so-called “prevention paradox,” which means that individualized treatment is prioritized over preventive measures because the former (individualized medical care) is perceived as more exigent, even though the latter (preventive measures) may be more cost-effective. However, the data are clear that both are necessary to increase the health span of Americans or any population, and investment in public health needs to be adequate.

To prolong health span, we will need to overcome the prevention paradox. One possible avenue to promote preventive measures is to use tax benefits and reimbursement structures to incentivize healthcare providers to incorporate individualized prevention into the care provided to patients. Professor Lindsay Wiley points to several real-world examples of programs implementing this approach, including the ACA’s preventive services mandate (which has recently been subject to legal challenges), tax benefits structures that trigger hospitals’ engagement in community needs assessments, and other reimbursement structures that encourage hospitals to offer flu testing and vaccinations to their patients.Footnote 18 Yet as Wiley notes, a meaningful alignment of public health and healthcare systems requires more investment on both prevention and collective concerns.

Another avenue is to create a legal infrastructure in which public health departments provide data and monitoring to support healthcare providers. For example, stronger public health–clinical care alignment may allow public health entities to utilize population-level data and assist the medical care delivery system in “identifying ineffective or inappropriate clinical care.”Footnote 19 This entails recruiting public health practitioners with expertise in health promotion and prevention, with an emphasis on older adults’ health.

13.1.2 Reshaping Geriatric Care

Even with the needed focus on a healthy life span throughout the ever-longer “old age,” older adults often do experience age-related illnesses and decline in physical and cognitive functioning. As a result, older adults are more vulnerable to frailty, falls, disability, and injury or acute illness than their younger counterparts. Further, approximately 80 percent of people sixty-five and older have one or more chronic conditions, and half have two or more such conditions.Footnote 20

Yet geriatric care in the US remains inadequate, in terms of both workforce size and quality of care, despite the essential expertise that geriatric medicine provides in the care of older adults. However, understanding the physiologic changes with aging and managing older people with multiple chronic conditions and complex needs require that expertise. For example, according to one estimation, there are only 7,500 certified geriatricians in the USFootnote 21 – approximately half of the estimated number of practicing urologists (14,000)Footnote 22 and less than a fifth of practicing OB-GYNs (50,000).Footnote 23 As we describe further below, the low number of geriatric specialists leads to a shortage at a time when there is an increasing demand for geriatric health care.

By way of comparison, consider the way in which the demand for pediatric services created by the mid twentieth-century “baby boom” transformed pediatric care. Between 1938 and 1955, the number of pediatricians in the US tripled,Footnote 24 and by the end of the 1960s, the American Association of Pediatricians had almost quadrupled in size compared to 1950.Footnote 25 During this period, pediatricians in the US shaped a “new,” holistic form of pediatric practice, in part in response to the jump in the number of births after World War II.Footnote 26 One would expect the US health system to similarly evolve to meet the needs of the growing population of older adults, but this has not been the case. Indeed, the current number of certified geriatricians reflects only a minuscule increase in comparison to the already small number of certified geriatricians almost two decades ago.Footnote 27

Thus, to adapt to the increasing number of older adults and the ensuing demand for high-quality geriatric services, there is a need to fundamentally invest in geriatric care. In doing so, policymakers should focus on four existing dilemmas: (1) how to attract and retain high-quality geriatric specialists; (2) how to improve training and education; (3) how to design settings and systems in which proper care can be provided; and (4) how to create robust social and digital infrastructure for care and health promotion.

Let us begin with the healthcare workforce. Over the past two decades, an array of reports and studies have consistently shown that the US healthcare system experiences significant shortages of board-certified geriatricians, and this supply–demand gap is projected to increase in the near future.Footnote 28 There are several reasons for this deficiency, but one particular factor is compensation: Geriatricians have lower salaries than general internists and family medicine physicians, even though geriatric certification generally requires additional training (most commonly in the form of fellowships) that goes beyond what is required for internal or family medicine certification.Footnote 29

When the relatively low compensation is combined with the perceived lower prestige of the profession and the complex clinical needs associated with some older adults, specializing in geriatric health care may be less appealing. To make things even more complicated, the widespread reliance on the relative value unit (RVU) as a metric to assess clinical productivity for reimbursement purposes fails to adequately account for the time and effort needed to provide high-quality care for older adults with complex healthcare needs.Footnote 30 As a result of these structural features of geriatric care, some medical professionals may choose an alternative, higher-income medical specialty. In fact, some physicians cannot even afford to become geriatric specialists. And the problem does not end with certified medical geriatricians: Similar shortages exist across other elder-care professions, from nurses, to pharmacists, to social workers, to other healthcare providers.

To address the workforce problem, policymakers should craft plans to recruit high-quality healthcare professionals with geriatric specialty. In addition to increasing wages, policymakers should use scholarships, loan forgiveness, clinical internships, and other financial incentives to attract qualified geriatricians, as well as to solve reimbursement and financial disincentives.Footnote 31

We do not think that machines can or should replace clinical support workers. A number of scholars have argued that so-called “care robots” – which have been recently introduced to support elder care around the world – can address shortages in skilled labor and may “increasingly play a role in supplementing lower-skilled work and providing new avenues for patient engagement.”Footnote 32 Insofar as artificial intelligence (AI) and care robots can assist patients and healthcare workers with performing technical, administrative tasks such as reminding a person to take routine medication, this may ameliorate some of the demands on the geriatric workforce. Nevertheless, the use of care robots also exposes patients to digital devices with far-reaching recording and surveillance capacities, which raises significant concerns about the ability to protect patients’ privacy and autonomy. Moreover, we are wary that the use of AI and robots could distract decision-makers from the need to invest in the elder-care workforce. Thus, to the extent robots are being used to provide care, it should be in addition to – not instead of – human physicians and providers.

However, recruitment and retention of a high-quality workforce is not enough; the education and training provided to healthcare professionals, both geriatricians and nongeriatricians, should also be improved. Although people sixty-five and older use various health services – including hospital visits and emergency medical service responses – at much higher rates than the rest of the US population, many healthcare professionals lack the sufficient competency to understand and deal with the challenges associated with age-related frailty and vulnerability. A 2008 Institute of Medicine report pointed to “lack of faculty, lack of funding, lack of time in already-busy curricula, and the lack of recognition of the importance of geriatric training” in medical schools as the primary reasons for this inadequacy.Footnote 33

Another recent report found that the US healthcare system is rife with “neglect, insensitivity, and even abuse” when it comes to treating older adults.Footnote 34 The report documents physicians’ use of demeaning language directed toward older adults and concludes that the “lives of older patients are seen as less valuable than younger patients.”Footnote 35 It also finds that elder abuse in nursing homes and other institutional settings results in part from insufficient staff training that could otherwise prevent such disturbing phenomena. These findings reflect the entrenched ageism in the US healthcare system – ageism that was exacerbated during the COVID-19 pandemic, when institutionalized older adults were put at great risk. Although more than 165,000 nursing home residents have died from COVID-19,Footnote 36 the conditions that gave rise to the deaths of institutionalized older Americans have still not been addressed postpandemic.

To improve the geriatric competence of healthcare workers, researchers have proposed several strategies that pertain to both geriatricians and nongeriatricians. First, with respect to all healthcare workers, both in clinical care and in public health, researchers recommend training such workers in a variety of settings, including nursing homes and older people’s homes, as well as incorporating simulations and virtual learning into their training. Adopting this strategy would change the status quo, whereby most of the training of healthcare professionals takes place in hospitals, even though older adults receive large portions of care in nonhospital settings. Second, with respect to providers who pursue a career in geriatrics, researchers suggest conditioning the granting of license and certifications on proof of competence in the care and health promotion of older adults, as well as raising minimum training standards for certain paraprofessionals, including certified nursing assistants and personal care aides. While these proposals address different objectives and target different healthcare and public health professions, they all share the underlying recognition that respectful and effective care for older adults begins at the training stage and requires regulators to take proactive approaches.

As the population ages, healthcare professionals – regardless of whether they specialize in geriatrics – will increasingly need to be attuned to elder mistreatment. Healthcare professionals are often in the best position to recognize the warning signs of elder abuse, neglect, and exploitation. In addition, they may be in a unique position to intervene. Since abusers often isolate their victims, older adults’ healthcare providers may be their only meaningful human contact other than their abuser. When healthcare providers do not recognize mistreatment, they not only miss a potentially valuable opportunity to intervene but may end up facilitating the mistreatment. For example, a provider who does not recognize a caregiver’s abuse of a patient may implicitly signal to the caregiver or patient that the mistreatment is “normal” and that it can continue with impunity.

Similarly, it will be ever more imperative for healthcare professionals to have a sophisticated understanding of how to support patients with diminished cognitive capacity. For example, healthcare professionals will increasingly need to not only be alert to the possibility that their older patients may be experiencing cognitive decline, but also recognize when additional support or time may be needed for patients to be able to make informed choices.

As for the settings in which care is provided, most older adults in the US live in their homes or in a family member’s house.Footnote 37 By contrast, 1 million older adults (4 percent of the entire older adult population) live and receive care in nursing homes. While this may seem a relatively small number, it is important to address the consequences of providing care to older adults in nursing homes and other institutional settings. The COVID-19 pandemic exposed the inadequacy of some institutional long-term care facilities in the US, including care provided in many nursing homes. The devastating number of COVID-19-related deaths, noted above, alongside long-standing evidence about the poor conditions surrounding many nursing homes across the country, has led to major proposals for designing long-term care in people’s homes and other noninstitutional settings. There is also a pressing need to redesign nursing homes to prevent infectious diseases and maintain human contact.

While scholars disagree about whether nursing homes – as a distinct concept – are necessarily part of the problem or potentially part of the solution, all seem to recognize that most US nursing homes are currently underresourced and prone to abuse and neglect. According to a 2022 report, 90 percent of nursing homes suffer from inadequate staffing,Footnote 38 and this is particularly the case when it comes to settings with high percentages of Black residents.Footnote 39 To address this problem, in April 2024, the US Department of Health and Human Services adopted a final rule setting a minimum staffing threshold for nursing homes that participate in Medicaid and Medicare.Footnote 40 Some elder advocates, however, argue that more ambitious standards are necessary to meaningfully improve the conditions in nursing homes.Footnote 41

The US nursing home problem is exacerbated by the fact that (1) Medicare, which provides health insurance to people aged sixty-five and older, covers only peripheral aspects of long-term services, and (2) to be eligible for long-term services under Medicaid, one must first exhaust their own financial resources. Moreover, Medicaid coverage for long-term care is limited and reflects a preference for nursing homes over private homes and community-based settings in that it requires states’ programs to provide funding for long-term care in nursing homes while at the same time conditioning the provision of care in people’s homes on the availability of discretionary “waiver programs.”Footnote 42

To be sure, recent decades have seen a shift in federal policy with the aim of moving people from nursing homes and institutions to community-based settings, a shift that was initially bolstered by the Supreme Court 1999 decision in Olmstead v. L.C. ex rel. Zimring,Footnote 43 which held that undue institutionalization constitutes disability discrimination. But the Court also considered states’ budgetary constraints, holding that a state could avoid liability if it showed that it had a “working plan” for placing disabled people in community-based settings. The upshot is that, even after Olmstead, many states keep long waiting lists for Americans who wish to receive home- and community-based services.Footnote 44 Thus, expanding in-home Medicaid coverage would allow more older adults to receive care in their homes – which is where they usually prefer to reside – instead of in nursing homes. The goal should be a coordinated continuum of care rather than discrete systems with lack of care continuity and shared medical records.

The final problem addressed here is that the social, digital, and legal infrastructure in the US is not strong enough to allow all older adults to take advantage of recent technological developments, most notably telehealth. For example, according to estimates, 21–42 million people in the US do not have access to broadband internet,Footnote 45 and those who are connected to the internet may lack the digital literacy necessary to receive high-quality telemedicine care. This is ironic, given that older adults in remote and rural places – where it is sometimes hard to find specialists in various medical disciplines – are more likely to benefit from telehealth but are less likely to have access to the digital infrastructure needed for such services. Thus, the unequal access to digital devices and broadband internet may increase health disparities across socioeconomic and geographic lines, notwithstanding the promise that telemedicine holds.

In sum, the myriad problems described earlier require an overhaul to the structural and institutional systems that affect the compensation, education, training, and evaluation of geriatricians and other healthcare professionals, as well as the systems and environments in which care is provided.

13.2 Financing a Twenty-First-Century Elder-Care System

The question of how to finance health care for the older population is particularly challenging given the demographic trend that is the focus of this volume, as well as the sociopolitical situation surrounding the US healthcare system’s funding. For example, Medicare is facing “significant financing issues.”Footnote 46 According to 2023 federal reports, the annual cost of Medicare is projected to increase from 3.9 percent of GDP in 2023 to 6 percent of GDP by 2045. As a result, Medicare’s Hospital Insurance trust fund – which covers inpatient hospital care and posthospitalization care in rehabilitation or nursing facilities – is projected to become depleted as early as 2031. The main reason, of course, has to do with the aging population, which increases the number of beneficiaries and consequently the costs of insurance coverage. Existing proposals to solve this problem include increasing Medicare tax rates, introducing changes into Medicare’s funding mechanisms, and increasing the program’s enrollment age.

So, what can be done to tackle the financing issue? Let us begin by noting that adopting some of the proposals described in Section 13.1 might actually save money for the US health system. In an ideal world, that money, in turn, could be used to finance additional services and programs aimed at prolonging Americans’ health span. The problem is that federal spending is often siloed; money saved in Medicare isn’t given to the CDC for public health infrastructure investment, for example. And the way federal budget scoring occurs, long-term investments in public health are often scored as deficits on the books, if the expected benefits occur outside a ten-year budget window.Footnote 47

Nevertheless, there is robust evidence that increasing public health investments is likely to reduce healthcare costs associated with treating disease and injury by advancing prevention at the population level. One study, for example, estimated that ex-ante interventions aimed at preventing obesity, diabetes, and hypertension would accrue considerable health-related benefits at reduced costs compared to the costs associated with ex-post clinical treatment.Footnote 48 In fact, the decrease in cardiovascular disease and other causes of ill health reduces healthcare costs, with a fourteenfold return on investment.Footnote 49 However, America’s health has been worsening,Footnote 50 with rising infant and maternal mortality, obesity, diabetes, homicides and suicides, loneliness, worsening mental health, and drug addiction. In combination, these contribute to rising healthcare costs.

There is also evidence that providing care in homes and community-based settings is not more expensive – and may even be cheaper per individual – than institutional settings and nursing homes. One study examined data pertaining to the expansion of home- and community-based services in Ohio over a twenty-year period and found that the expansion did not result in a significant increase in expenditures.Footnote 51 Another study, which analyzed data from the vast majority of US jurisdictions, estimated that the provision of home- and community-based services actually saved money in comparison to the costs associated with the provision of care in nursing facilities.Footnote 52 All of this is to say that the US healthcare system can do more to improve older adults’ health with the money already spent on health-related measures.

But even if creating a health system with well-balanced investments in public health and medical care would entail an additional investment of public funds, such an investment is essential. An aging population that is unhealthy in large part will bring new financial stresses, not to mention increasing stress on family caregivers. In 1965, when Medicare was enacted, President Lyndon Johnson declared that older Americans would no longer “be denied the healing miracle of modern medicine.”Footnote 53 He referred to Medicare protection as “the hand of justice” that is offered to older adults who themselves had given “a lifetime of service and wisdom and labor to the progress” of the US.Footnote 54 As these statements make clear, federal legislation concerning healthcare funding for the elderly has been inextricably linked to norms about caring for older adults.

Long-term care is one of the areas where investment of public funds is most needed. Although the Community Living Assistance Services and Supports Act (CLASS) established a social insurance program aimed at addressing this issue, the program has never been activated because of its sole reliance on participants’ premiums (with no additional tax dollars), which was insufficient to ensure solvency. Given the limited coverage offered by Medicaid and Medicare, as described earlier, and the fact that the vast majority of Americans do not have private insurance coverage for long-term care, it is imperative to increase funding for such care – either under Medicaid or a potential universal social insurance policy – to allow Americans to receive care in the setting they prefer and to relieve some of the burden on older adults’ caregivers.Footnote 55

Indeed, the failure to ensure adequate funding for long-term care has been detrimental not only to the older adults who need such care but also to their formal and informal caregivers. With respect to formal caregivers, federal labor laws in the US have historically provided insufficient wage and work-hour protections to direct-care workers who provide older adults with clinical services, emotional support, and assistance with bathing, dressing, and other everyday activities. This state of affairs has resulted, at least in part, from concerns that improving labor standards for such workers would increase the costs of long-term care and ultimately force older adults to receive fewer services.Footnote 56 While some progress has been made in this regard (most notably by extending Fair Labor Standards Act protections to home-care workers in 2013), many home-care workers – who are disproportionally women and people of color – are still underpaid and often unable to gain overtime payments.Footnote 57 Moreover, poor working conditions for direct-care workers may lead to high turnover rates and low motivation among these workers, which run counter to the interests of older adults themselves.

The lack of a social insurance policy for long-term care also affects informal caregivers, who are disproportionately women and often have to reduce their own household or workforce productivity to care for elderly family members. In fact, family members and friends frequently have no choice but to fill the caregiving vacuum, resulting in tremendous monetary and emotional costs.Footnote 58 As Professor Allison Hoffman has demonstrated, these costs are currently not accounted for under existing policies.Footnote 59 And taking them into consideration, Hoffman notes, helpfully “redefines the scale of the problem of long-term care.”Footnote 60 Addressing the problem will require a multidimensional solution, but one thing seems clear: Part of the solution should involve increased state and federal funding. As the final section will illustrate, investing in the health of older adults may actually have unexpected benefits for society at large.

13.3 Imagining Healthy Longevity: Unleashing a Third Demographic Dividend

Our contention is that the measures proposed in this chapter to improve Americans’ health span could unleash a “third demographic dividend” whereby society reaps the benefits – both economic and noneconomic – of having a healthy and engaged older population.Footnote 61

According to the conventional narrative, a first demographic dividend occurs when children survive and age into employability.Footnote 62 A second demographic dividend results from labor supply then exceeding the share of the population that is below working age. As a result of this shift in labor supply, society experiences an increase in production and benefits from a stronger workforce, strengthening the economy and investments that further increase longevity. As people live longer, they are more likely to save money and prepare for retirement. With more productivity and national wealth, increased life expectancy creates opportunities and incentives to invest in education and human capital.

Longevity, however, has more to offer US society. If we develop the proper public health, social, and legal infrastructure, our society can extend health span and enable older adults’ social capital to confer generative impact through more paid employment, national or local service, volunteering, and social and political activism. This, in turn, could give rise to a third demographic dividend in which society can thrive due to both healthy longevity and transformations to a society that enables the opportunities of our longer lives to support all ages flourishing.Footnote 63

To have a sense of what such a society might look like, consider the education arena. As students in the US try to fill the educational gaps that resulted from the COVID-19 pandemic, the American education system could benefit from older volunteers assisting students in various academic and social tasks. Such a mentoring and tutoring program – the “Experience Corps” – is already operating in twenty cities across the country, connecting senior adults with students in public elementary schools who need assistance in reading and other aspects of academic performance. The senior volunteers benefit not only from the human interaction and generative impact that the program facilitatesFootnote 64 but also from improved cognition, mental health, and physical strength.Footnote 65 Similar programs can address other social goals. For example, during public health emergencies such as the COVID-19 pandemic, older adults could take on community roles aimed at supporting their neighbors, sharing advice, and building resilience. As a different kind of example, many retired health professionals were called back into service to fill work shortages during the pandemic.Footnote 66 Here again, such programs would not only contribute to the public’s health but also reduce older adults’ loneliness and promote their self-esteem and sense of belonging.

Other examples pertain to the potential contribution of older adults to labor and consumer markets. Many of today’s jobs do not entail physically strenuous work and could be fulfilled by older adults. Requiring employers to provide reasonable accommodations for aging workers regardless of disability status may allow more older adults to retain their jobs.Footnote 67 Further, employers are increasingly recognizing that intergenerational teams are more proactive and innovative. They are developing flexible approaches to retirement and time commitments, which ultimately benefit adults of all ages. To incentivize employers to hire older adult workers, Fried and her colleagues suggest using subsidies that would help to reduce employers’ costs associated with employing older adults, for example, by ensuring that Medicare would serve as a primary payer for health insurance for such employees.Footnote 68 Another way to increase work opportunities among older adults is retraining programs that allow people to develop new expertise and careers.Footnote 69

As people live and work longer, more age-friendly products will be needed to fit their needs. That, in turn, is likely to give rise to the involvement of older adults in the development and design processes of such products. A new market that relies upon the contribution of older adults as expert designers and customers may emerge – and with it, expanded jobs for all ages.

To be sure, healthy longevity alone is not sufficient for creating a society in which older adults are active participants in every aspect of social life; we also need to find the ways to counteract ageism and establish the social institutions that would allow such participation. But ensuring the health of older adults – through public health investments and a healthcare system better prepared for this specific and growing population – is necessary for unleashing the third demographic dividend. Indeed, research suggests that one of the major factors hindering the emergence of large-scale programs, such as the Experience Corps, is older adults’ chronic conditions and disability.Footnote 70 Thus, if we want to enable the unique and valuable social capital of older adults in an aging population, we first need to make sure they have the conditions to stay healthy.

13.4 Conclusion

This chapter has explored some ways in which the US health system has to change to accommodate the 100-year-old American. It identifies the creation of optimal health for a longer life as the health system’s primary goal, and points to two primary avenues to achieve this goal: (1) investing in a public health system that can increase health span for the whole population and (2) improving geriatric care and health systems. As for the first avenue, we argue that implementing population-based preventive measures under the auspices of the public health system could reduce chromic conditions among older adults and lead to better health outcomes in the long term. As for the second avenue, we argue that the provision of high-quality and age-friendly care requires a more robust and well-trained geriatric workforce, focusing on providing a coordinated continuum of geriatrically informed systems of care and using emerging technologies to make health care more accessible for everyone. Further, enabling engagement that older adults seek will improve health in aging while supporting societal flourishing.

As this chapter has shown, the sharp increase in the share of older adults in the US population poses significant challenges for the American healthcare system. This is particularly true with respect to funding, the subject of the chapter’s second section. We argue that even though there are no easy solutions for the financing dilemma, some of our reform proposals could actually save money in the long term.

Ultimately, the constant increase in life expectancy not only poses challenges but also creates unique opportunities: If we find the ways to incorporate health into older adults’ so-called extra years, older adults will be able to use their experience and expertise to contribute to society by engaging in work, volunteering, leadership, and advocacy activities. Perceived this way, longevity can have ripple effects that have the potential to create a long-lived society in which all ages can thrive.

14 Making the Best of Long-Term Care for Seniors

The 100-Year Life explores the opportunities longer life will provide, assuming individuals have sufficient financial resources to fund their longer lives. Many people save too little for their retirement, but the federal government’s two largest social insurance programs – Social Security and Medicare – keep millions of seniors out of poverty. The Social Security old-age benefit partially replaces lost wages, using a statutory retirement age as a proxy for being unable to work.Footnote 1 The federal Medicare program provides health insurance at subsidized rates to beneficiaries based on age, starting at age sixty-five.Footnote 2 In addition, the federal government provides grants to states for state-run Medicaid programs, which provide health insurance to impoverished Medicaid-eligible persons, including seniors.

This chapter addresses a frequently overlooked retirement expense – the cost of nonmedical custodial care. Most individuals aged sixty-five or older will require custodial care – Long-Term Care (LTC), also known as Long-Term Services and Supports (LTSS). LTC includes assistance with activities of daily living (ADLs), such as eating, bathing, dressing, getting in and out of a chair, walking, toileting, and continence; and instrumental activities of daily living (IADLs), such as grocery shopping, banking, bill paying, and filling prescriptions.

Most LTC is unpaid family care because most seniors and their families cannot afford the cost of paid LTC. Paid LTC is very expensive. For example, in 2021, the average annual cost of a year of LTC was:

  • $108,408 for a nursing home private room;

  • $94,896 for a nursing home semi-private room;

  • $54,000 for a one-bedroom apartment in an assisted living facility; and

  • $59,484 for forty-four hours per week of LTC in the senior’s home.Footnote 3

Medicare generally does not cover LTC, although many people assume it does.Footnote 4 State-run Medicaid programs provide significant LTC funding – but only to Medicaid-eligible persons with low income and almost no savings. Access to paid LTC currently is a patchwork crazy-quilt of public (federal, state, and local) and private funding mechanisms.

This chapter first explores the implications – for current and future seniors and their caregivers – of increased longevity and other trends on unpaid family LTC and on publicly funded and privately funded paid LTC. Second, this chapter surveys alternative means of accessing and funding LTC. Third, this chapter notes LTC trends, innovations, legal developments, and proposals that might improve the LTC outlook for seniors and their families.

14.1 Unpaid Family LTC

Ninety percent of seniors who need LTC receive unpaid care from members of their “family,” defined broadly.Footnote 5 Two-thirds rely exclusively on unpaid family care, and another quarter combine unpaid family care and paid care. In 2021, for example, 38 million family caregivers provided 36 billion hours of unpaid care.Footnote 6 The aggregate economic value of unpaid family LTC is enormous, both in absolute terms – about $600 billion in 2021 – and in relative terms – about 20 percent of US healthcare costs.Footnote 7

Family members often share caregiving duties. Spouses and adult children – generally daughters – provide most unpaid care. Spouses usually provide more hours of care per month than other types of caregivers. Women provide over 60 percent of unpaid care, although men provide more unpaid care today than in the past. Unpaid female caregivers average eighty-one hours per month of caregiving, while unpaid male caregivers average sixty-five hours per month. Seniors who require LTC often have unmet LTC needs if their caregivers’ availability to provide care is limited.

Multiple demographic trends may impact the future availability of unpaid family caregivers. The overwhelming majority of female caregivers under age sixty-five also work for pay, and the percentage of women who work outside the home is projected to increase. Also, women are projected to work to older ages in the future. Increasing participation in paid work may reduce the availability of family members for unpaid caregiving. Potentially offsetting these trends, remote work and improved technology might increase the availability of family members for unpaid caregiving.

Women also have increased their educational attainment and delayed having children, which may limit the scheduling flexibility of “sandwich-generation” caregivers (30 percent of family caregivers) to care for both their children and their parents. Also, fertility rates in the US have declined and the large Baby Boomer cohort is aging. By 2035, seniors aged sixty-five and older will outnumber youths aged eighteen and younger in the US for the first time. The caregiver support ratio, which compares adults in the prime caregiving age group (45–64) to seniors in the age group most likely to require LTC (eighty and over), will shrink going forward.Footnote 8

Rates of “gray” divorce have increased, although divorced seniors often find new partners. Among seniors aged seventy-five and older, two-thirds of men have a spouse or partner, compared to just one-third of women.Footnote 9 Unmarried seniors, especially unmarried white women, increasingly live alone. The number of “elder orphans” (seniors with no support network) is projected to increase in the future.

Family members are becoming caregivers at younger ages. About one-third of adults aged forty and younger and one-quarter of Millennials already provide unpaid care to family members.Footnote 10

Older Americans and their unpaid family caregivers will be more diverse in the future. Cultural differences in attitudes toward family responsibility and the care of seniors will create divergent patterns of unpaid and paid care. Some cultures have norms of providing unpaid care to seniors in the community. In such cultures, several generations of a family often live together, with younger generations sharing the care of elderly members of the family in the multigenerational home. Other cultures have norms of minimizing the burdens older generations impose on their adult children. Seniors from such cultures are more likely to seek out paid LTC.Footnote 11

Seniors of color, in particular Black seniors, are more likely to require LTC – and to require it at an earlier age – than white seniors. Appalling, persistent racial and socioeconomic health disparities, which are evident throughout the lifespan, increase and accelerate disadvantaged seniors’ need for LTC. Myriad environmental stressors (e.g., pollution, lead paint, food insecurity) and poverty contribute to such disparities. In addition, research over the past two decades establishes that pervasive, lifelong exposure to social and structural oppression and racism cause premature biological aging – weathering – of Black people regardless of their income or wealth.Footnote 12 Compared to white seniors, Black seniors are more likely to be disabled, to reside in a nursing home, and to receive substandard care.

Both rates of poverty and the likelihood a senior will need paid LTC increase with age. The need for LTC is highest in the eighty-and-older senior cohort, the fastest growing segment of seniors. Poverty rates for elderly women exceed that for elderly men. In the future, as longevity increases, more seniors are likely to require paid LTC and to qualify for Medicaid-funded LTC.

The potential negative effects of caregiving on family caregivers – in particular women – who provide unpaid LTC are underappreciated. Unpaid family caregiving entails significant – albeit hidden – costs. To provide care at home, family caregivers with paying jobs often must reduce their work hours and effort, or exit the paid labor market entirely, reducing employer-provided health insurance coverage and retirement plan contributions. These hidden costs “help explain the much higher poverty rates for older women relative to men.”Footnote 13

Family caregivers often incur substantial out-of-pocket costs to care for their family members. In 2016, the average annual out-of-pocket expenses for a family caregiver were $7,000 overall and 27 percent of the income of Millennial caregivers.Footnote 14 Family members who must pay these costs reduce their own income and retirement savings.

Family caregivers often experience stress and anxiety, especially when a dependent family member’s health deteriorates, and care becomes more complex. Seniors with multiple chronic medical conditions or with Alzheimer’s disease or related dementias (ADRD) require the most intensive caregiving. Over time, the stresses of caregiving can negatively impact the health of the caregiver. In addition, healthcare providers increasingly delegate to family members medical tasks that go beyond IADLs and ADLs, such as wound care and operating medical equipment (e.g., dialysis equipment).Footnote 15 Many caregivers are uncomfortable performing such tasks, yet perform them because no one else is available to help. Also, family caregivers generally receive little guidance about how to provide care. The need to complete frustrating administrative tasks, such as insurance paperwork, often adds to caregivers’ stress and anxiety. When seniors’ care needs exceed family caregivers’ capabilities, paid LTC becomes a necessity.

14.2 Paid LTC

Many Americans incorrectly assume that Medicare covers the cost of paid LTC for seniors. Medicare covers “medical” treatment – narrowly and clinically defined – but generally does not cover LTC. Nor does the federal government provide any other universal LTC benefit. State-run Medicaid programs (jointly funded by the federal government and states) provide LTC to seniors living in poverty. Strict legal rules, which vary from state to state, limit Medicaid eligibility to individuals with little income and very little wealth – in many states, not more than $2,000 of assets.

If a senior has too much wealth to qualify for Medicaid, but not enough to fund LTC, the senior must spend down her assets to qualify for Medicaid. The low asset threshold for Medicaid eligibility yokes the beneficial receipt of Medicaid-funded LTC to unintended financial risks created by Medicaid-mandated impoverishment. Notwithstanding the strict Medicaid eligibility requirements, Medicaid pays a significant percentage of aggregate US LTC costs.

The likelihood that a senior will enroll in Medicaid increases with the length of time the person requires paid LTC. The lower a senior’s lifetime earnings, the sooner they are likely to enroll in Medicaid. By the fifth year of requiring paid LTC, the vast majority of seniors – including the top 20 percent of all income earners – are enrolled in Medicaid.Footnote 16 The duration of needing LTC varies. Patients with ADRD often require many years of LTC. About 18 percent of women and 14 percent of all seniors require five or more years of LTC. On average, women need 3.7 years of LTC and men need 2.2 years of LTC. For seniors “with less education, lifetime earnings, and wealth,” both disability and the need for LTC “come earlier and last longer.”Footnote 17

14.2.1 Nursing Homes as the Default Delivery Site for Medicaid-Funded LTC

Skilled nursing homes always have been the default delivery site for Medicaid-funded LTC. At the creation of Medicare and Medicaid in 1965, both programs “adopted a medicalized model of care, prioritizing the use of licensed providers and institutions,” which made caregiving outside of licensed care facilities “invisible” and financially “unsupported.”Footnote 18 Nursing homes typically are large institutional medical facilities, more suited to deliver skilled medical care than LTC. Patients in nursing homes include post–acute-care (recently hospitalized) patients, for whose skilled nursing care the facility is reimbursed at a high Medicare rate; and LTC patients, for whose custodial care the facility is reimbursed at a low Medicaid rate.

Long-standing shortcomings of providing LTC in nursing homes include (1) poor infection control; (2) high staff turnover and chronic worker shortages; (3) neglect of patient needs and low quality of care, often due to understaffing; and (4) patients’ loss of privacy, agency, and control over their environment. The COVID-19 pandemic exacerbated these shortcomings.

The pandemic increased the chronic shortage of care workers and high staff turnover in nursing homes, both of which are associated with lower-quality patient care. This shortage has many causes. Nursing home-care workers (other than nurses) earn very low wages and often juggle jobs at multiple nursing homes, which increases infection risks. Care work in nursing homes was always a dangerous profession, due to infection risk and the physical demands of the job. COVID turned it into one of the most dangerous jobs in America. In addition, entrenched racial hierarchies are common in nursing homes. Managers generally are white, but care workers disproportionately are Black women and other women of color. Care workers express the feeling they are working on “the plantation,”Footnote 19 invoking the long history in our country of relegating Black workers to low-wage, dirty, domestic servant work.Footnote 20

Improving working conditions for care workers is essential as a matter of racial justice and to reduce the acute shortage of LTC workers. Reversing systemic racism in LTC work will require nursing homes and other healthcare organizations to provide higher pay and employee benefits to care workers; to promote Black frontline care workers and other workers of color to management and board positions; to recruit Black students for internships and management positions; and to empower care workers to direct more of their own care work.

Black care workers and other care workers of color also can organize their own LTC businesses. Bronx-based Cooperative Home Care Associates (CHCA) provides an example of a successful LTC business managed and owned by Black women and other women of color. Founded in 1985 by twelve care workers, CHCA now employs 2,300 care workers. It offers its employees free training, health insurance, a pension plan, union membership, regular work hours, and an hourly wage of $16. Employees also can elect to buy a share of stock in the business for $1,000, by paying $50 one time and $3.65 per week for five years. About half of CHCA employees own stock in the company. By improving working conditions and promoting its employees’ agency and economic dignity, CHCA achieved much lower employee turnover than most home-care providers. Lower turnover translates to better patient care. CHCA is a model for other minority-owned LTC businesses.

The pandemic also reinvigorated long-standing policy critiques of legal rules that make institutional nursing homes the default setting for Medicaid-funded LTC. In a 1992 case, Olmstead v. L.C., the US Supreme Court held that federal disability law prohibited states from forcing persons with mental illness to live in segregated, congregate-care facilities to receive medical treatment, if the care of the patients could be less intrusively integrated into their home community.Footnote 21 Olmstead supports an argument that persons who need LTC should not be forced into segregated, congregate nursing homes – the Medicaid default setting – but instead should have access to home- and community-based services (HCBS) if their care needs do not require them to be in a nursing home.

14.2.2 Growth of HCBS as an Alternative to Nursing Home LTC

Years before the pandemic, concerns about poor infection control, chronic staffing shortages, and poor quality of care in many nursing homes led states to gradually begin offering HCBS as an alternative to nursing home LTC.Footnote 22 The default Medicaid setting for LTC continued to be nursing homes, but states applied for federal waivers that allowed them to experiment with offering HCBS to some, but not all, state Medicaid patients. HCBS is provided to seniors at “home” in a wide range of residential settings, including a single-family home or apartment and assisted living apartments.Footnote 23

Infection risks are lower in the HCBS setting, and seniors strongly prefer HCBS to nursing home care. As of 2020, patient demand for HCBS was so great that around 700,000 patients were on waiting lists to receive HCBS. The average wait time to receive HCBS was thirty months, although wait times varied widely between states. After the pandemic highlighted the need for additional HCBS, states and the federal government increased funding for HCBS. Proposed legislation would further increase funding for HCBS.

To date, however, state Medicaid HCBS programs are still operating under federal Medicaid waivers, meaning HCBS is not a universal mandatory Medicaid benefit. The hesitancy to make HCBS a universal Medicaid benefit stems from the immense cost of such an expansion. The cost per patient of providing LTC generally is lower in the home than in the nursing home setting.Footnote 24 The aggregate public cost of HCBS ultimately may be higher than that of nursing home LTC, however, because more patients want HCBS than nursing home LTC. As HCBS expands, patients only receiving unpaid family LTC may enroll for paid LTC through the HCBS program – converting some unpaid LTC into new government-funded paid LTC. LTC experts observe that the chief difficulty with expanding access to HCBS is containing public costs by structuring the benefits around the senior population that would go into a nursing home absent the provision of HCBS.Footnote 25

14.2.3 Programs of All-Inclusive Care for the Elderly

Over the past decade, various demonstration projects have shown promise to provide HCBS, while containing costs and providing noninstitutional LTC. For example, Programs of All-Inclusive Care for the Elderly (PACE) allow seniors who want to stay in their “home” (broadly construed) to combine traditional Medicare benefits and LTC in a managed care plan, using a team-care approach and a capitated (per enrollee) payment structure instead of a fee-for-service structure.Footnote 26 In addition to providing medical care, PACE “centers” provide adult day care, nutritious food, and recreational activities to seniors, along with transportation from the senior’s home to the center and back. PACE enrollees must be nursing home-eligible and live near a PACE center. Seniors who are eligible for both Medicare and Medicaid (dual-eligible) qualify for enrollment in PACE. Seniors who are enrolled in Medicare but ineligible for Medicaid can pay a premium to enroll in a PACE program. About 90 percent of PACE enrollees are dual-eligible. Over thirty states offer at least one PACE program.

14.2.4 Naturally Occurring Retirement Communities

Certain innovative HCBS programs are well suited for particular residential settings. For example, in dense urban areas, large rent-controlled apartment buildings with a high percentage of seniors, referred to as Naturally Occurring Retirement Communities (“NORCs”), can become a focal point for efficient delivery of HCBS. Paid LTC staff working in these buildings can assist seniors on site. Seniors in NORCs are, on average, in the low- to middle-income ranges, and about half are usually also eligible for Medicaid. NORCs are funded by a combination of government funding, philanthropic funding, and contributions from residents.Footnote 27

14.2.5 Medicare Advantage Plans

Since 2020, Medicare Advantage (MA) plans have been allowed to offer Special Supplemental Benefits for the Chronically Ill (“SSBCI”), with a primary focus on improving social determinants of health. The benefits available to patients with complex chronic conditions include pest control, indoor air quality, nonmedical transportation, meal delivery, produce and grocery delivery, and virtual visits to reduce social isolation.

Expansion of next-generation programs that incorporate LTC – including PACE, NORCs, and MA plans – will facilitate data collection and reviews of their effectiveness and costs. For example, a stunning 2023 study concluded that MA plans received $75 billion in government overpayments, prompting calls for reform of the MA fee structure.Footnote 28

14.2.6 Older Americans Act Programs

In addition to federal grants to state-run Medicaid programs, the federal Older Americans Act (OAA) provides grants to states for programs supporting Americans aged sixty or older.Footnote 29 Seniors qualify for OAA benefits without regard to the Medicaid income or asset tests. OAA programs include meals delivered to the senior’s home (e.g., Meals on Wheels), congregate meals served in the community, caregiver supports, home care, adult day-care services, and assisted transportation. Local Agencies on Aging can provide information about OAA-funded programs offered to seniors in the community.

14.2.7 Aid and Attendance for Military Veterans and Their Spouses

A subset of seniors – military veterans and their surviving spouses – may qualify for another public source of LTC funding, referred to as Aid and Attendance, through the US Department of Veterans Affairs.Footnote 30 Veterans and their surviving spouses who qualify for a military pension benefit may be eligible for supplemental pension benefits if they are “medically rated” to require LTC (either “Aid and Attendance” or “housebound” care). Each type of pension and supplemental benefit has specific eligibility requirements (e.g., based on the length of active military service and whether the veteran died while on active duty). The veterans’ benefit program has a wealth test but allows much greater wealth than Medicaid.Footnote 31

14.2.8 Private LTC Insurance

Another potential LTC funding source – albeit private rather than public – is Long-Term Care Insurance (“LTCI”).Footnote 32 The nontrivial risk of needing catastrophically expensive LTC is exactly the type of risk against which consumers might insure. At the start of the twenty-first century, over 100 insurance companies sold stand-alone LTCI policies to consumers. Consumer purchases of LTCI were modest, however, in part because of the availability of Medicaid as the LTC payer of last resort.Footnote 33

Over time, the LTCI insurance market contracted sharply. Insurers discovered they initially underpriced LTCI premiums. State insurance regulations prevented insurers from prospectively correcting the mistakes through premium increases on existing policies, leading almost all insurers to exit the LTCI market. The few remaining insurers reduced their risks by significantly increasing premiums on new LTCI policies and declining to cover a high percentage of prospective purchasers with underlying health conditions. As the LTCI market contracted, many employers that previously offered LTCI as an employee benefit eliminated it from their employee benefit package. Currently only 7 million LTCI policies are in force in the US. Just 11 percent of seniors own LTCI policies, which paid about 8 percent of LTC costs in the US in 2016.

As the LTCI industry contracted, state insurance commissioners and regulators urged federal and state policymakers to adopt policies that might make LTCI more appealing to consumers and increase private, individual funding of LTC risk. Although state legislatures and the US Congress enacted legislation intended to encourage the purchase of LTCI, such incentives have not been particularly effective. Income tax deductions for LTCI premium payments – available only to a very small percentage of taxpayers – provide one example of an ineffective LTCI subsidy.

Long-Term Care Insurance Partnerships (“LTCIPs”) provide another example of legislation intended to increase LTCI purchases. LTCIPs allow state Medicaid eligibility without the usual extreme spend-down of assets if a consumer purchases qualified LTCI. For example, assume Diana purchases a qualified LTCI policy that covers $100,000 of LTC. If Diana later requires LTC, exhausts her $100,000 LTCI benefit, and subsequently applies for Medicaid, the state Medicaid asset limit for Diana is increased by $100,000. The younger and healthier a consumer is when she purchases LTCI, the lower the LTCI premiums will be.

Despite widespread adoption of LTCIP statutes by most states, the early consensus among researchers was that the adoption of LTCIPs failed to significantly increase the purchase of LTCI. A recent study found otherwise, however, partly because “the effect of LTCIP appears over time and the effect is mostly driven by partnerships set up after 2010,” which were not considered in earlier studies.Footnote 34 The new study concludes that the adoption of an LTCIP “increased the uptake of LTCI coverage by 1.64 percentage points[;] reduced Medicaid uptake by 1.46 percentage points[;]” and reduced federal Medicaid expenditures by $36 for each senior. Notwithstanding the continued availability of Medicaid as a payer of last resort, consumers purchased LTCI to protect their assets and increase their bequests. This study offers some hope for LTCIPs. In addition, LTCIPs could be combined with a mandatory state or federal social insurance program, funded by new taxes, with a tax opt-out for purchasers of LTCI.

Another LTCI development is that insurers have created hybrid insurance products that blend LTC coverage with other popular forms of coverage, such as life insurance or annuities. The hybrid products generally do not qualify as LTCI, for purposes of state LTCIP programs.

Policymakers disagree about whether LTC should be privately funded through the individual purchase of LTCI, or publicly funded through premiums or payroll taxes for a state or federal LTC social insurance program. Although the availability of Medicaid-funded LTC discourages the purchase of private LTCI, repealing Medicaid-funded LTC would be deeply unpopular with Americans. In addition, private individual LTCI still would be too costly for millions of Americans. State or federal LTC social insurance proposals, which would reduce the need for Medicaid-funded LTC, seem more politically plausible, but only if the funding mechanism for the proposal does not turn the political tide against it. Allowing an opt-out for purchasers of private LTCI would reduce the public cost of the social insurance program.

14.3 Public LTC Social Insurance Developments and Proposals
14.3.1 State LTC Social Insurance Program Developments

Some state legislatures have considered making LTC benefits available to all state residents, including those ineligible for Medicaid. In 2019, the state of Washington enacted the country’s first state LTC social insurance program.Footnote 35 Washington’s Long-Term Services and Supports Trust Program (now called the Washington Cares Fund) is the first universal state social insurance program covering LTC. The Washington program is funded by a new 0.58 percent ($58 per $10,000 of wages) payroll tax on wages, which the state began to collect on July 1, 2023. A payroll tax opt-out is available for those who previously purchased their own private LTCI. The state LTC benefits of up to $36,500 can fund in-home care (including care by family members), home modifications, transportation, food delivery, caregiver training, and respite care. Hawaii also provides LTC to residents but funds the care out of general revenue instead of pairing social insurance LTC benefits with a dedicated tax. Other states also are considering LTC proposals.Footnote 36

14.3.2 Federal LTC Social Insurance Program Proposals

Experts in LTC have long argued for a universal federal LTC social insurance program, but repeated congressional attempts to create such a program have failed. For example, in 2010, as part of the Affordable Care Act, Congress enacted the Community and Living Assistance Services and Supports (CLASS) Act, a federally subsidized voluntary LTC insurance program with no eligibility exclusions. The CLASS Act was soon repealed, however, due to concerns about the financial viability of the program. The decade since its repeal has been a time of transition for LTC programs. Although traditional Medicare continues to exclude LTC, MA plans and PACE-managed care plans with LTC benefits are available to seniors in some but not all geographic areas.

Senior care experts and policymakers continue to advocate for a universal federal LTC program. Situating an LTC funding program at the federal level would eliminate LTC eligibility variation between states and could relax draconian state asset tests. Expanding LTC eligibility would, in turn, increase the costs of the LTC program.

Health economists have modeled the distributional effects and costs of a new federal social insurance program for LTC. Low- and middle-income Americans would disproportionately benefit. Many seniors and their families would replace unpaid family LTC with new paid, federally funded LTC. The projected ten-year costs of the new LTC are in the trillions – ranging from 5.7 to 8.1 trillion, depending on how LTC eligibility is defined.

The costs of a new LTC social insurance program could be reduced by making LTC available only to seniors who cannot perform three or more ADLs. Costs also could be lower if medical science discovers ways to reduce or defer the onset of diseases that produce the highest LTC costs. For example, ADRD risk might be reduced through exercise and diet.Footnote 37 In addition, just delaying ADRD onset could reduce projected LTC spending significantly.Footnote 38 Even with such medical breakthroughs, however, the cost of new federally funded LTC services would be enormous.

From a political perspective, long-simmering concerns about the solvency of the existing Medicare trust fund – much less the funding of new universal LTC benefits – provide a difficult fiscal backdrop for enacting a federal LTC program. On the other hand, the COVID pandemic highlighted the significance of the care economy in the US and created political momentum to improve LTC, increase access to paid LTC at home, and expand public funding for paid LTC.

15 Immigration and the 100-Year Life

The quality of a civilization is judged by how well older people are treated.

—Pope Benedict XVIFootnote 1

One of every two babies born today will live until age 100. This chapter is about the immigration-related implications of this remarkable demographic change, which only five decades ago would have seemed inconceivable. Even with medical advances, as our population ages, a larger proportion of the population will be unable to live independently. Immediately the question arises: Who will care for our elderly population? The US will need many more care workers and, overwhelmingly, they will be migrants.

While, in the popular imagination, elder care is typically associated with nursing homes, a report from the Department of Health and Human Services estimates that fewer than 5 percent of seniors reside in institutional settings like nursing homes.Footnote 2 The senior population overwhelmingly continues to reside at home. Thus, most care workers will not work in hospitals or nursing homes; rather most care work will be delivered in the home. Much of this home care will not be subsidized by government; the US stands out among rich OECD countries in the relatively paltry sums that it dedicates to long-term care for seniors.Footnote 3 Most home care is paid for by a patchwork of financial sources – very occasionally with state aid, but mostly with funds from seniors themselves, their children, and nonfamilial sources, such as nonprofits and churches.Footnote 4

It bears emphasis: Most of this at-home care is unpaid and provided by family members. However, paid home care has been steadily growing. Twenty-five percent of senior citizens need significant assistance with “ADL” (activities of daily living).Footnote 5 With over 55 million people who are senior citizens, the percentage of people who now need paid help is already significant and will surely continue to rise. This is also true because of compositional effects; with lower fertility, a larger portion of the population becomes older. Even if eighty becomes the new sixty, that still means a higher percentage of the total population will be frail, and a lower percentage of the population will be available to help them.

We have long understood the implications of the aging population for health care – this is a primary reason that the growth of jobs in the healthcare sector has long outpaced the growth of jobs in the regular economy. Further, the pace of growth for home-care aides is even more extraordinary. One recent report projected that between now and 2026, jobs in home-care settings will grow by 41 percent.Footnote 6 Yet, while the pace of growth of jobs remains high, the salaries are modest. Pay for aides is not much higher than the minimum wage in most states.

Trends are already clear. The home-care sector looks a lot like other sectors in which Americans are typically not employed and undocumented migrants dominate. One need only think, for example, of farm work – a field dominated by undocumented labor. This work is difficult, and the pay is low. Moreover, home-care work is particularly well suited to the undocumented population since it is difficult for immigration officials to police work that occurs inside people’s homes.

How has the US typically managed the need for a large and steady group of low-skilled workers? There is a large gap between what immigration institutions purport to do and what actually happens. That is, the stated goal of immigration institutions is twofold. First, these institutions seek to ensure that aliens are screened ex-ante (i.e., preentry) for suitability to particular visa types; and second, that they are sanctioned if they do not abide by the terms of their visas. Thus, if the US is looking for a law-abiding temporary elder-care worker, it would screen for a “short-term” type, with caregiving skills and no criminal record.

With respect to screening and sanctioning, the reality is that this system only works right now for skilled workers. If a visa candidate is a computer scientist with a prospective job in Silicon Valley, the candidate is carefully screened ex-ante or preentry – she must submit her academic credentials, her prospective job, and undergo a detailed background check. It should be noted that the visa type for which the computer scientist is eligible (typically H1B) provides a path first to permanent residency, and later to citizenship. This means that the formal system carefully screens for those with the right qualities to not only do skilled work but also become American citizens. Therefore, the potential sanction is clearly implicit. A skilled person who does not abide by their visa terms potentially forfeits their opportunity for American citizenship. Again, here I am describing the system for skilled workers. For unskilled workers, the outcome, in sharp contrast to the skilled system, involves the de facto permanent residence of 12 million undocumented persons, the overwhelming majority of whom have never been screened or sanctioned.

How did this come to be? Outside of guest worker programs, which are primarily used for seasonal agriculture (H2A) and tourism and other seasonal industries (H2B), there is no equivalent system of comprehensive preentry screening for low-skilled workers. In some countries, such as the anglophone Caribbean Islands, which are the highest source of guest workers on a per-capita basis, the state seeks to reduce unemployment and buttress remittances by sending citizens overseas. Thus, the state works alongside American agricultural and tourism companies to recruit potential low-skilled guest workers to apply for visas. The state then helps these otherwise poorly resourced guest workers to source and submit the required visa application paperwork at the US Embassy.

Thus, if you are a farm worker or tourism worker from Jamaica or Antigua, you may receive help. But as a practical matter, most low-skilled workers who are poor residents of developing countries simply lack the resources to compile the documentation, pay the visa fees, and undergo a screening process. Moreover, many American companies are perfectly willing to hire undocumented persons. Thus, if you are low-skilled and seeking work in the US as a practical matter, your easiest choice is to cross the border without documentation, or to enter on some other sort of easier-to-acquire visa, such as a visitors’ visa (B2), knowing fully well that you will work in violation of the visa’s terms.

Law Professors Eric Posner and Adam Cox explain how this system has evolved. For the low-skilled portion of the population, as a practical matter, rather than screening all persons (as they are required to do in theory on the basis of their obligations under law to screen ex ante), immigration officials have only pursued those who commit non–immigration-related crimes. Thus, in reality, the system as it relates to low-skilled workers is an ex-post system in which undocumented entrants, who later provide evidence of undesirability (through their contact with the criminal justice system), are screened only after their entry, and then deported. For low-skilled workers, the system is currently designed to sidestep ex-ante screening and ex-post sanctioning (unless the low-skilled worker commits a non–immigration-related crime).

Difficulties in negotiating compromises on immigration reform reflects that many Americans are unconvinced that policymakers and immigration enforcement officials can design, and enforce, a credible program in which temporary workers will in fact be temporary.Footnote 7 To build broad-based political support for a temporary worker elder-care program, policymakers will have to design a program that in fact screens for workers who are competent caregivers, who are seeking temporary work, and who will keep with the terms of their visas and return to their countries of origin. Recognizing that for decades the political climate has been decidedly restrictionist, political actors have long sidestepped hard questions about how to design a program that will admit large numbers of low-skilled migrants who actually comply with the temporary terms of their visas. This is why the 100-year life matters for immigration. Perhaps the aging of the population and the inevitable need for care workers will force policymakers to confront these questions.

A large population of elderly citizens will likely mean that the US will have a large population of temporary workers who have no reasonable prospect of becoming permanent residents. The influential political philosopher Michael Walzer has warned of the dangers of a long-term population of temporary residents without the rights and responsibilities of citizenship in constitutional democracy. His view is that most (if not all) persons admitted should have a path to permanent residency and citizenship. Many law professors (including myself) share his expansionist sentiments. Yet, as law professors, we also need to confront the reality that most Americans do not share our expansionist inclinations. Whatever our inclinations may be, there is a desperate need for an academic focus on institutional design. Specifically the need to focus on how immigration institutions can do what Americans want them to do – screen for migrants who abide by the rules of their visas and sanction those who do not.

I believe that I have a model for how such immigration institutions may be designed. My own region of origin – the Caribbean – currently supplies many home-care aides in two states with disproportionate representation of seniors, Florida and New York. As a scholar of “low-skilled” migration from the Caribbean, in this chapter I consider questions of immigration institutional design in light of lessons learned from how Caribbean home-care aides currently work and travel. In Section 15.1, I provide details of the lives of these undocumented workers to consider how we might incentivize compliance with immigration rules.

In Section 15.2, I contend that Caribbean workers who are working (ultra vires) while on “visitors’” (B2) visas have already provided a model that institutional design experts might want to replicate. Caribbean home-care aides on visitors’ visas understand that they are not supposed to work. However, since the B2 visa permits a maximum of a six-month stay after entry, they also understand that they are unlikely to be penalized for working as long as they do not stay in the US for longer than six months on any one visit. If they violate this rule, the US is unlikely to renew their visas.

Thus, they have devised a system to comply with the six-month rule – job splitting. This is a pattern whereby home-care aides split their work between two workers, each of whom works for six months per year before turning over the job to a companion care worker for the remaining six months. Thus, each worker is in fact temporary. In any given year, they spend no more than six months in the US, before returning to their country of origin and then coming again the following year. The workers comply with the six-month rule because they feel secure in the knowledge that they will be permitted to come the following year. This pattern typically continues over several years. An upside of job splitting is that it leads to continuity of care, since the elders who they care for have the same two caregivers over several years. This is important; indeed, continuity of care is prioritized in the elder-care literature.

That this system persists not only for “low-skilled” workers who pick tomatoes but also for “low-skilled” workers who care for grandparents speaks volumes about the long-term likelihood of its persistence. But this is unnecessary. In Section 15.3, I argue that most of these workers are in fact “good types,” who could have been favorably screened ex-ante for elder-care visas. I propose that we urgently devise a system that permits temporary entry of elder-care workers. If they are permitted long-term temporary visas in which they can work in the US for a few months per year over several years, they have every incentive to comply.

We must confront the reality of a shadow system of undocumented persons in home care and design a system to replace it. Postponing such questions is no longer sustainable in light of the 100-year life.

15.1 A Model for Elder Care: Lessons from Caribbean Home-Care Aides

In the popular imagination during the pandemic, elder care became synonymous with nursing homes. However, most elderly Americans do not live in nursing homes. Nor do scholars of elder care want them to live in nursing homes. There had been an increasing consensus among scholars that we need to prioritize “aging in place,” that is, noninstitutional solutions to elder care, with an emphasis on keeping the elderly in their homes and communities.Footnote 8 The pandemic has reinforced this sentiment. Based on data, over 23 percent of people who died from COVID complications in the US were nursing home residents.Footnote 9 The disastrous impact of COVID in institutional settings has underlined the need for more sustainable elder care, particularly in-home elder care. Thus, I begin with a different population, which I believe distinctively illustrates the challenges of redesigning an immigration system to provide sustainable care to an aging population: home-care aides.

I have spent most of my life in a region of the world – the Caribbean – that disproportionately supplies the workers who take care of the American elderly. Although formal data are hard to find (perhaps because so many persons are undocumented), it is inarguable that the Caribbean supplies the majority of home-care aides in at least two regions of the country, namely Florida and New York (the first of which has the second-highest proportion of elderly populations). This chapter is based in part on research into Caribbean migrant workers, many of whom are home-care aides.

Of the migrant workers who have been seriously studied (primarily in agriculture, construction, tourism, and food plants), workers in elder care are undoubtedly the least studied population. Home-care aides are by definition “out of sight.” While this population has been insufficiently studied within the US (perhaps because so many of them live in the homes of their elderly employers and are paid in cash), the same is not true in the Caribbean. The home-care aide population regularly sends money to their countries of origin and, in so doing, provides a steady pool of cash to their families and their countries.

Much information can be ascertained from their remittances, which have become indispensable to the foreign exchange reserves of Caribbean central banks. Their sizable earnings provide a clue to the unique importance of this population – not only to their countries of origin but also to elderly Americans. It is not an exaggeration to say that in-home elder care in both Florida and New York would collapse if Caribbean migrant workers disappeared.

How did home-care workers providing services “under the table” become so important? The oft-told narrative is as follows. A New York or Florida family has a parent or grandparent who is no longer able to live independently. The family visits a few nursing homes and finds either the facilities unattractive or the costs prohibitive, despite having access to Medicare since state coverage of nursing home care is paltry in the US (certainly in comparison to other rich OECD countries). Moreover, for many families, nursing home workers seem overextended, raising concerns as to whether their elderly relative would be properly cared for.

Of course, in-home elder care also has its challenges – for example, the provision of care is governed by a patchy network of licensing and regulations (with some localities having no licensing requirements or regulatory framework at all) – leading to concerns about the quality of care. Naturally, many families prefer in-home care. Moreover, many discover that they can provide care for their grandparent more cheaply through in-home care, particularly when such care is subsidized by state insurance that may provide an in-home care aide for a few hours each week (typically the state will only subsidize those who are home healthcare aides, that is, those who have some basic medical training). However, usually the state will provide only a fraction of the care that the elderly relative needs. Thus, many families supplement their state-subsidized care with lower-cost options; they hire home-care aides who are undocumented and pay them under the table. In the absence of a formal state-supported care infrastructure (such as exists in many other developed countries, including in Western Europe), families create a home-care infrastructure themselves.

In New York and Florida, home-care aides are predominantly Caribbean womenFootnote 10 who are not licensedFootnote 11 even though families are clearly satisfied with their services as evidenced by their multi-year tenure with the same families. How do these women come to be home-care aides? For a Caribbean woman who is not university educated (and thereby ineligible for most skilled work visas in the US), there are basically three options to work in the US. The first is what we typically think of as agricultural guest work – a yearly sojourn (at least pre-COVID) on an H2A visa to work on a US farm for several months. For most women, unfortunately, agricultural visas are not a practical option; their recipients are overwhelmingly men. The second option is to be a documented guest worker in the tourism or other seasonal sector on an H2B visa. This, for example, might involve working in a hotel in Aspen, Colorado. These guest workers unsurprisingly pay taxes. They also incur other expenses, such as living expenses for staying in staff quarters that are deducted from their salaries by the hotels. From a take-home pay perspective, the most desirable option for many Caribbean women is the third option, namely, undocumented care work. I use the word “undocumented” to mean both those who are either working without any visa whatsoever (the popular understanding of the term “undocumented”) and those who have visas that preclude legal work but who work anyways.

Why is care work so popular? Having spoken to Jamaicans who have done tourism work and home-care work, they will explain that they are better off as undocumented home-care aides than as documented guest workers. The money is steady, their living expenses are often covered since many live in their clients’ homes, and they avoid tax obligations. Nearly every Jamaican knows of some relative or friend working as a home-care aide in the US. (I say this as a native Jamaican, with only slight exaggeration!)

Some of these home-care aides are “undocumented,” in the popular understanding of the term, in that they have typically overstayed their B2 visas (known informally as visitor’s visas). I highlight a few of the terms under which visitor’s visas are typically issued. First, the visa applicant is expected to provide accurate information about her travel intentions and her historical behavior, that is, including her historical record of abiding with the terms of visas. That is, if she is applying for a visitor’s visa, she should really be intending to make a short-term visit. Second, the visa recipient agrees that she will not impose welfare costs on the government. Third, the visa recipient agrees only to visit and not work, as well as to exit the US within the prescribed time period, which for B2 visas is six months after entry. Some Jamaicans who work under the table initially enter on B2 visas that then expire. They then become undocumented in the typical understanding of the term since they no longer have visa documentation.

However, there is a different pool of home-care aides that I would like to highlight for the purposes of this chapter because their work patterns provide important lessons about institutional design. Many Caribbean home-care aides who engage in unauthorized work have come up with unconventional and interesting mechanisms of maintaining their job security. Setting aside the fact that they are working (a clear violation of the terms of their B2 visas), they take pains not to overstay. That is, on every visit, they make sure they stay no more than six months after their initial entry. In so doing, they seek to preserve the possibilities that their visas will be renewed. Thus, the pattern is as follows. Beverly, a hypothetical in-home aide, enters on January 1, Year 1. She leaves on June 30, Year 1. She returns to her country of origin for the rest of the calendar year. In Year 2, she enters on January 1 and leaves on June 30, returning to her country for the rest of the year. And so the pattern continues.

If Beverly is only in the US for six months, is her job surely at risk? Not so. In order to maintain the continuity of her work with elderly clients, she “splits” her job. That is, Beverly is the home-care aide for the first six months. She is then replaced by Janet – a sister, a cousin, or a close friend – who works as the home-care aide for the other six months. I refer to this pattern as job splitting.

15.2 Why Job Splitting Matters

Any competent immigration lawyer would agree that these Jamaican women who work while they are on visitor’s visas are not in fact complying with their visa terms. Yet on further examination, what these women do is in fact quite innovative. What is striking about job splitting is that these women do not “overstay” while simultaneously maintaining their employment for when they return. They have in essence created a type of “de facto” job security. That is, an elder-care worker may only work for six months of the year, but she has done it for the last ten years.

Moreover, for students of the literature on elder care, there is an unanticipated benefit of their efforts to avoid overstaying while maintaining their jobs. Job splitting has the upside of helping to ensure continuity of care for their elderly clients. Continuity of care is a major theme in the elder-care literature. That is, by splitting the job, Janet and Beverley are able to provide elder-care services to one client for ten years. Rather than receiving services from many different home-care aides, the client only receives services from Beverley and Janet.

Researchers have long emphasized that continuity of care matters for patient well-being. Immigration institutional design has clear implications for patient well-being and longevity. Researchers have long emphasized that continuity of care matters for patient well-being, and the COVID pandemic only served to reinforce its importance. Indeed, continuity of care may have life-or-death implications. During the pandemic, elderly persons who were cared for at home by one long-term caregiver were less likely to be exposed to COVID infections, to be hospitalized, or to die than their counterparts in nursing homes. Additionally, one study contends that an elderly person fares better when the worker who takes care of her perceives herself to be the long-term caregiver of that elderly person. Why is this? Persons who believe themselves to be long-term caregivers are more likely to advocate for their clients to receive good health care, or to speak candidly about what they perceive to be in the best interests of their patients.

In support of this theory, I turn to the nursing home context. There appear to be differential outcomes in infection and death rates in those nursing homes with long-term employees with minimal turnover versus those homes where turnover rates are higher.Footnote 12 Again, one reason for these differential outcomes is obvious. A high-turnover staff is more likely to introduce infection to a nursing home. But there are other reasons. Where staff turnover was lower, staff were more likely to be invested in providing good care to the nursing home residents and to advocate for COVID prevention protocols to protect the residents.

Surely this is relevant to planning for the 100-year-old citizen. As we prepare for a world where centenarians become the norm, I argue that this is the model that the US should try to emulate when addressing questions of institutional design in immigration – creating incentives for migrants who care for the elderly to invest in the longevity of their jobs. Migrants who invest in the longevity of their jobs are typically also invested in the longevity of their patients. If they are secure in the knowledge that their visas will be renewed – provided that they abide by the terms and do not overstay – they will be invested in the well-being and good health of their clients, who they will be likely to serve over several years.

15.3 Designing a System within Restrictionist Political Realities

In a landmark book, Law Professor Hiroshi Motomura calls on Americans to treat lawful immigrants as “Americans in Waiting,” largely entitled to the benefits of citizenship. Motomura is concerned primarily with what the larger goals of immigration should be, given the underlying constitutional and moral commitments of American democracy. His work typifies the expansionist flavor of much immigration law scholarship. Scholars typically focus on admitting more migrants, for longer periods, and with a more robust group of rights. Although I am very sympathetic to these expansionist goals, I believe that they are not realistic in light of current political constraints, given that the dominant immigration sentiments appear to be restrictionist.

What do I mean by restrictionist constraints? Most Americans want fewer immigrants who are long-term permanent residents. Moreover, they are skeptical of temporary migrant programs, believing that guest workers will inevitably overstay and become long-term residents. Although restrictionist policies were promoted most passionately by the Trump administration, it is already clear that restrictionist immigration policies have outlived President Trump. One need only consider what appears to be an emerging bipartisan political backlash to the perceived increase in the numbers of persons applying for asylum at the southern border.Footnote 13

A more realistic view of what is possible with restrictionist political realities is articulated by Law Professor Cristina Rodriguez, who quite clearly understands the inevitable trade-off between the number of migrants admitted and the rights they receive upon admission. She termed this trade-off “the admissions-status dynamic.” Responding to Motomura’s challenge to treat more migrants as “citizens-in-waiting,” Rodriguez characterizes the challenge as follows:

According to the dynamic, more immigration translates into diminished support for immigrants’ rights, and more robust immigrants’ rights translate into less support for immigrant admission. To put it crudely, if cheap labor is suddenly transformed into expensive citizens in waiting, the doors to immigrants may well close altogether. If we commit to treating immigrants as citizens, we may well erode what support exists for largescale immigration, giving rise to policies that more strictly limit the number of people permitted to enter. Such restrictions would be justified on the ground that we must be highly selective about those we admit given that they will be presumptively entitled to join our political community. In short, a society may be willing to absorb large-scale immigration only if it can maintain tight control over the benefits that accrue to immigrants, reserving for citizens alone the most expensive or most valued goods of citizenship. Trends in immigration law and policy in the United States reflect this trade-off.Footnote 14

Rodriguez’s perspective is relevant to any program aimed at admitting elder-care workers. If Rodriguez is right (as I believe she is), realistic immigration proposals will need to assure Americans that the elder-care workers who are being admitted will not be long-term members of the political community, with entitlements to the benefits that come with this status. The US’s refusal to design an immigration system that includes these assurances is, in part, responsible for the large undocumented population. Any program designed to recruit guest workers specifically to provide elder care needs to clearly establish that these workers are temporary.

The key in my mind is not only to look for ex-ante signals of temporary intent but also to incentivize compliance. If guest workers are assured that they could come for six months, with a near guarantee of visa renewal if they abided by the terms of their visa requirements, they will take compliance seriously.

Other incentives for compliance could also be built in. For example, a portion of their earnings might be held in escrow to be released when they return to their country of origin. However, these other incentives will pale in importance to the primary incentive – namely an assurance of visa renewal if they comply. These guest workers would be not unlike the aforementioned Caribbean home-care aides, who are “self-enforcing” precisely because they feel secure that their visitors’ visas will be renewed as long as they do not stay in the US longer than six months.

Moreover, to ensure continuity of care, one of their visa requirements might be that they provide care services to clients who they have serviced in the past (with a clear exception if the client dies). This would provide an additional incentive to do what the Caribbean home-care aides are already doing. That is, they return to provide care services to their former employers, secure in the knowledge that their jobs will be waiting for them the following year when they return. It is possible to model “de jure” after what Caribbean home-care workers have been doing “de facto.”

We already know that most of these workers are in fact “good types” who would likely have been favorably screened. We know this because of the market – these elder-care workers would hardly have been able to maintain employment with the same family over several years if they were not providing competent care services. Moreover, recall Cox and Posner, finding good visa applicants is primarily an informational problem; a state is seeking to find enough information to ascertain whether a potential entrant matches its type preferences. Notably, the communities of origin for Caribbean elder-care workers are small and tightly knit – if a person has a poor reputation, the word will spread. If someone is an incompetent caregiver, they are unlikely to get referrals or positive recommendations from other care workers (who are always being asked for referrals). Of course, the state cares about matters that families may not care about (e.g., their inclination to comply with their visas), so family approval is not the final word, but it is surely a good sign.

There would of course be other requirements. For example, in conducting visa screening, the US might quite reasonably want to conduct detailed background checks, such as ensuring that the applicant has no history of abuse against the elderly. However, these prospective elder-care workers are not Silicon Valley-bound computer scientists; they cannot present university diplomas or letters from professors and employers in the formal market to serve as testament to their background and character. Yet overcoming the challenges of ex-ante screening in nontraditional populations – whose members may lack access to the resources needed to credibly document their backgrounds – seems particularly possible in the small Caribbean countries from which the elder-care workers that I have described in this chapter originate.

These workers typically originate from small towns and villages – they are known at multiple levels of community life. Indeed, this is precisely how Canada screens its guest workers – relying on Caribbean governments to share information about visa candidates ascertained through cooperation with clubs, churches, and other community organizations. That Spain has been able to implement a similar model in screening guest workers from Morocco – a much larger country with arguably a more challenging risk profile than the Caribbean Islands – is indicative that the utility of this approach of transnational cooperation to augment screening capabilities goes beyond small island countries of origin.

Finally, to maintain certain standards of care, one might also want to institute some sort of licensing regime, in which those who have demonstrated some historical competence in elder care receive a certificate licensing them to provide elder care in the US. If a person has historically been involved in elder care (such as the aforementioned Caribbean women), they should be initially eligible even if they lack formal credentials, while providing them an incentive to pursue additional training to maintain their licenses in the future. Since such licensing is typically provided by the states rather than the federal government, the federal government might simply want to stipulate that visa recipients demonstrate that they have met licensing requirements, to provide an additional incentive for caregivers to become licensed.

15.4 Conclusion

What we will end up with is a large population of people who are in essence guest workers in perpetuity – assured of the right to return if they only stay a few months and leave and return to their country of origin every year. This of course is precisely what the political philosopher Michael Walzer has warned against – the presence of a long-term pool of persons who live in perpetual “guest-workerness,” with no realistic means of participating in the democratic experiment. Would a great constitutional democracy really tolerate the presence of such a population within its borders?

This of course is an important question for any constitutional democracy to grapple with. But it appears to be a question that Americans have already answered – even if some of us find the answer deeply troubling. For example, Americans already tolerate guest workers in perpetuity in their farm work and tourism worker programs – it bears emphasis that a significant proportion of visa recipients in these programs are multi-year repeat participants. And the huge undocumented population is in essence a de facto population of permanent residents with no political voice of their own – they are typically only able to act politically through their allies. Thus, what Americans are prepared to tolerate is perfectly clear; the question of the “justice” of what they perceive to be tolerable is different. I believe the outline of the guest worker program for elder-care workers is practicable within the aforementioned political constraints. As we approach the era of the 100-year life, this provides a clear model for how we might proceed to design a system that provides a robust pipeline of well-screened migrant workers.

16 Science Fiction, Legal Fiction, Political Fiction, and the 100-Year Life

A child born in the West today has a more than 50 per cent chance of living to be over 105 … This is not science fiction.Footnote 1

The claim by Lynda Gratton and Andrew Scott that “the 100-year life” will become the norm for cohorts born in the Western world today is startling. It also is, contrary to the authors’ characterization, “science fiction.” By “science fiction” I do not mean that it is necessarily wrong – science fiction sometimes proves prescient, as with Jules Verne’s predictions of electric submarines and space travel. But the claim is “science fiction” within the dictionary definition: a “story featur[ing] hypothetical scientific or technological advances.”Footnote 2 For Gratton and Scott’s claim to come true, biomedicine will need to make advances against aging that – for now – remain hypothetical.

Imagining a 100-year life requires us to engage not only in science fiction but also in legal and political fiction. I do not mean “legal fiction” in Blackstone’s sense – a fiction that litigants and judges use to rationalize particular jurisdictional results, such as the fiction that defendants before the King’s Bench committed trespass in Middlesex county.Footnote 3 And by “political fiction,” I do not mean that the 100-year life is a House of Cards-style thriller about officeholders in Westminster or Washington. Rather, the journey to a 100-year life will likely require new developments in law and politics that – as with their biomedical counterparts – remain hypothetical. Not only have we failed to achieve the biomedical advances that will allow 100-year lives to become the norm, but we have also failed to build the legal institutions and political coalitions that will foster those biomedical advances. As with Verne’s submarines, today’s fiction may become reality in the not-so-distant future. But the journey to a 100-year life will require creative solutions in the realm of law and public policy, just as it will require ingenuity in the scientific realm.

While other chapters explore the implications of the 100-year life for law and public policy, this chapter explores the role of law and policy in achieving century-long lifespans. Section 16.1 argues that for 100-year lives to become the norm within the time frame that Gratton and Scott envision, we will need to make extraordinary progress in reducing old-age mortality. These advances will need to be qualitatively different from the disease-specific innovations that attract the bulk of biomedical investment today.

Section 16.2 considers the role of law and policy in efforts to delay aging and death. It argues that patent law – the most familiar tool in the innovation policy toolkit – is ill fitted for the goal of achieving century-long lives. Many of the most promising longevity-enhancing innovations fall outside the legal and practical limits of patent protection. Even for new pharmaceutical and biologic products that lie closer to patent law’s core, the long time frame necessary to establish efficacy through clinical trials leaves few years for firms to monetize their innovations. Section 16.2 goes on to consider other legal mechanisms that can potentially sustain longevity-related research and development – specifically the private foundation and the for-profit corporation, which, unlike patents, can have infinite legal lives. Although nonprofit and corporate law have facilitated significant longevity-related investments in recent years, they have done so for reasons that are more idiosyncratic than systematic – and in ways that highlight the potential pitfalls of a private sector-driven quest for 100-year lifespans.

The chapter concludes by considering the political economy of public sector investment in longevity research. To achieve century-long lives, we will likely need governments – in particular, the US federal government – to commit to a moonshot investment in longevity akin to the Apollo project that brought Neil Armstrong and Buzz Aldrin to the lunar surface. But whereas the Apollo project commanded broad bipartisan support, a longevity moonshot is bound to encounter powerful political resistance. That wall of resistance may prove penetrable, but not easily so. Thus the path to a 100-year life will likely require major breakthroughs not only in the laboratory but also in the legislature.

16.1 A 100-Year Life Expectancy Is Still Science Fiction

Understanding the incredible optimism of Gratton and Scott’s predictions requires a brief primer in demographic terminology. Life expectancies are conventionally stated in period mean terms. Life expectancy at birth in a given year reflects the average number of life-years remaining for a newborn if age-specific mortality rates remain at that year’s levels. For example, life expectancy at birth in the US in 2021 was 76.4 years, meaning that if age-specific mortality rates remain at 2021 levels, the average age at death would be 76.4.Footnote 4 Most likely, babies born in the US in 2021 will on average live longer than 76.4 years because age-specific death rates will decline from 2021 levels. (The year 2021 was especially bad for period mean life expectancy because it coincided with the COVID-19 pandemic’s peak.) But of course, we don’t know how fast death rates will decline because we can’t see into the future.

Gratton and Scott offer life expectancy estimates in cohort median terms. By their estimates, 50 percent of babies born in the US in 2007 will live to be at least 104, and half of babies born in Japan that year will celebrate their 107th birthdays. Cohort lifespan estimates are in some ways more useful than period life expectancies because cohort estimates, unlike period estimates, apply to identifiable individuals (individuals born in a given country and year). By contrast, period mean life expectancy at birth in a particular year is not an estimate of the mean lifespan of individuals born in that year – it is a calculation of the mean lifespan of individuals born in that year under the unrealistic assumption that all age-specific mortality rates remain at that year’s levels. A downside of using cohort statistics, though, is that we can’t measure the cohort median until half a cohort has died. Barring catastrophe, we won’t know the cohort median lifespan for babies born in the US in 2007 until the late twenty-first or possibly early twenty-second century.

Gratton and Scott draw cohort lifespan projections from a 2009 paper in The Lancet by Kaare Christensen, Gabriele Doblhammer, Roland Rau, and James Vaupel (“CDRV”).Footnote 5 CDRV observe that “best practice” period mean life expectancy – the highest period mean life expectancy in any country in any given year – increased almost linearly at an annual rate of 0.25 years from 1840 into the 2000s. (Sweden was the best practice country for much of that period; Hong Kong is now.) CDRV then translate this observation about best practice period mean life expectancy into projections of cohort median life expectancy for eight high-income countries: Canada, Denmark, France, Germany, Italy, Japan, the UK, and the US.

To arrive at these projections, CDRV assume that period mean life expectancy in high-income countries will increase linearly at an annual rate of 0.2 years into the twenty-second century. They also assume that age-specific mortality rates will follow a particular path that generates annual increases of 0.2 years in period mean life expectancy. Mortality rates from age zero to fifty and from 110 on up will remain unchanged from 2006 levels, and mortality rates from age 50 to 110 will decline at a rate of 2.2 percent per year.Footnote 6

To recap: When Gratton and Scott say that “a child born in the West today has a more than 50 per cent chance of living to be over 105,” what they really mean is this: If cohort median lifespans in advanced economies grow as fast as CDRV project, then there is a 50 percent probability that a member of a high-income country cohort born in the first or second decade of the twenty-first century will reach age 105.

How plausible are CDRV’s projections? As CDRV note, previous prognosticators have often underestimated future life expectancy growth. As recently as 1990, an article in Science stated that “it seems highly unlikely that life expectancy at birth will exceed the age of 85”Footnote 7 – a threshold that Hong Kong surpassed in 2018. But while past projections of life expectancy growth have been unduly pessimistic, the growth rate that CDRV project appears to be extraordinarily optimistic – for at least two reasons.

First, CDRV project that period mean life expectancy in high-income countries will increase at an annual rate of 0.20 years from 2006 onwards, but we already know that – even before COVID-19 – those countries were not keeping up with that pace. The average annual rate of life expectancy growth across the eight countries in CDRV’s study from 2006 through 2019 was 0.15 years, and the rate for the US during that stretch was just 0.09 years. At a 0.15-year annual rate of life expectancy growth from 2006 onwards, none of the eight high-income countries in CDRV’s study would reach century-long life expectancies by 2120. At a rate of 0.09 years, US life expectancy in 2120 will be 88.1 years. For US life expectancy to reach 100 within a century, we will need to pick up the pace substantially.

Second, not only are CDRV’s period mean life expectancy projections quite optimistic relative to recent experience, but their projections for mortality rates are extraordinarily optimistic in light of historical experience. As noted earlier, CDRV project that mortality rates from age 50 to 110 will decline at a rate of 2.2 percent per year from 2006 to 2120. Yet over the entire period of the Human Mortality Database’s coverage from 1933 through 2019, the mortality rate for fifty-year-old Americans has declined at an annual rate of only 1.3 percent, or about three-fifths as fast as CDRV project. And the mortality rate for 100-year-old Americans has declined at an annual rate of 0.2 percent – less than a tenth of the rate that CDRV project going forward.

One might ask: How do CDRV arrive at such optimistic predictions if their model simply projects outwards from pre-2006 life expectancy growth? The primary reason is that CDRV’s model does not account for the different trajectories of mortality rates at different age levels. The US, like other high-income countries, made huge progress in reducing childhood and midlife mortality over the course of the twentieth century, which fueled similarly large gains in period mean life expectancy. In recent years, progress in reducing childhood and midlife mortality has slowed (and midlife mortality rates have actually increased in the US since 2010), but even if those mortality rate reductions picked up pace, they would have a relatively small impact on overall life expectancy. Indeed, even if we eliminated all mortality before age fifty, life expectancy at birth in the US would increase by less than four years. For century-long lifespans to become the norm, the US and other high-income countries will need to make extraordinary improvements in mortality rates at older ages.

Reducing mortality rates at older ages is not necessarily impossible, but it will require interventions different from those that are effective at younger ages. Disease-specific interventions can lead to large reductions in mortality at younger ages because if a younger person does not die of a particular cause (e.g., breast cancer), she is relatively unlikely to die of a competing cause in the near future (e.g., heart disease). By contrast, disease-specific interventions hold less promise for reducing mortality at older ages because if an older person does not die of a particular cause, she remains highly vulnerable to other fatal risks. For example, the Centers for Disease Control and Prevention estimates that a complete cure for Alzheimer’s disease – a top-five cause of death among Americans over age sixty-five – would extend overall US life expectancy by only about seven weeks.Footnote 8 To achieve the twenty-year life expectancy increase that CDRV project over a century, we will need to do more than play a game of disease-specific whack-a-mole.

This recognition raises two related questions. The first is whether any intervention – a lifestyle change, a miracle drug, a nonpharmacological therapy, or some other innovation, alone or in combination – can generate the all-cause mortality reductions at older ages that would be needed to realize CDRV’s forecasts. The second is whether, if there is any such intervention out there, countries can identify it and disseminate it to their populations. The former is, at bottom, a bioscientific question that lies beyond this chapter’s scope. The latter is a question of law, economics, and politics – and the question upon which the remainder of this chapter focuses.

16.2 The Limits of Law
16.2.1 Patents and Their Discontents

Discussions of law and innovation often begin – and too often end – with intellectual property – in particular, patent law. The promise of patent protection can encourage profit-seeking firms to undertake costly investments in the development of new technologies. But for most innovations with the potential to bring about century-long lifespans, the incentives generated by patent law are severely underpowered.

Consider, for example, intermittent fasting (fasting for one to two days per week), which – according to a recent article in the New England Journal of Medicine – appears to have “broad-spectrum benefits for many health conditions, such as obesity, diabetes mellitus, cardiovascular disease, cancers, and neurologic disorders.”Footnote 9 While the strength of these findings is a subject of much debate among biomedical researchers, the example of intermittent fasting provides a helpful illustration of patent law’s limits. A method for extending human lifespan through intermittent fasting would almost certainly lie outside the scope of patent eligibility under current law.Footnote 10 And even if Congress changed the law to permit patents on dietary innovations, it is hard to see how a patent on intermittent fasting could be enforced. A patent holder could not realistically determine whether individuals have gone twenty-four hours without eating and sue them if so. A firm that sponsored a clinical trial successfully showing that intermittent fasting extends lifespan would have little ability to monetize its investment.

Other promising longevity-enhancing interventions relate to drugs that have been off-patent for several years – and there, too, existing legal institutions generate weak incentives for research. Consider metformin – a drug that has been used to treat Type 2 diabetes for decades and that has been off-patent in its tablet formulation in the US since the beginning of the millennium. A 2014 study lifted hopes that daily metformin use might produce significant reductions in all-cause mortality even in nondiabetic patients.Footnote 11 But in the decade since that finding grabbed headlines, no pharmaceutical firm has conducted a clinical trial to see whether the results are robust. In 2015, the FDA green-lighted a proposal for a study to test whether metformin could reduce all-cause mortality in elderly patients, but the researchers who designed the trial have failed to attract the necessary funding – roughly $50 million.Footnote 12

Why have for-profit firms proved unwilling to finance a clinical trial of metformin – notwithstanding the potentially massive demand for a drug that reduces the risk of death across the board? In theory, firms can apply for new-use patents covering the application of an existing drug to treat a different medical condition – for example, the use of metformin to reduce all-cause mortality in nondiabetic patients. However, enforcing a new-use drug patent is extraordinarily difficult in practice. Typically, a pharmacist who fills a metformin prescription will not know whether the prescribing physician ordered metformin as an antidiabetic medication or an antiaging drug. And in many states, the pharmacist has a legal obligation to fill the prescription with the cheapest medicine available.Footnote 13 Thus, even when physicians prescribe a drug for a new use, the revenues are likely to flow to a low-cost generic manufacturer rather than the new-use patentee.

Even for new longevity drugs that are legally eligible for patent protection, long commercialization lags are likely to remain a significant impediment to profit-seeking investment. An analogy from the cancer context sheds light on the scope of the challenge. Eric Budish, Benjamin Roin, and Heidi Williams have shown that private sector firms are less likely to initiate clinical trials for drugs that treat slow-acting cancers than for drugs that target fast-acting cancers.Footnote 14 An important reason is that trials for slow-acting cancers last longer, thus taking up a larger chunk of the twenty-year patent life. By the time a pharmaceutical firm can win approval from the Food and Drug Administration (FDA) for an early-stage cancer treatment, the firm has only a short period of exclusivity within which to monetize its investment before generics can enter.

Aging is the ultimate slow-acting disease. Each step of the research process is likely to take longer for antiaging agents than for therapies that target quick killers. The antiaging treatment may require years to show any effect, and even if the effect on aging is immediate, the effect on clinical outcomes – for example, all-cause mortality – may not be detectable until much later. By that point, the patent clock may have run out.

A possible policy solution is to extend the exclusivity period for treatments that slow the aging process. Congress has enacted several other provisions that provide fixed periods of market exclusivity for manufacturers of new drugs, irrespective of whether the patent term has expired. For example, under the Orphan Drug Act of 1983, the manufacturer of a drug that treats a “rare disease” – typically a disease affecting fewer than 200,000 people in the US – can qualify for seven years of market exclusivity starting from the date of FDA approval, even if patent protection has run out. Aging is the polar opposite of a rare disease – it affects us all – but Congress could seek to incentivize the development of antiaging drugs by offering a similar exclusivity period. Such a statute might, for example, make eligibility conditional upon the manufacturer demonstrating a statistically significant reduction in all-cause mortality among the general population.

Exclusivity, however, is a double-edged sword. Market exclusivity incentivizes investment because it allows firms to charge higher prices for their products. Those higher prices tend to place products out of the reach of some consumers. Exclusivity thus implicates a trade-off between innovation and access, potentially resulting in the development of more antiaging interventions but not necessarily ensuring that those interventions reach more patients.

Another way for policymakers to encourage pharmaceutical firms to invest in the development of antiaging drugs would be for the FDA to confirm that a drug that reduces all-cause mortality – even if it does not target any specific disease – could achieve agency approval. Traditionally, the FDA has oriented its approval process around a “one disease, one drug” model, raising doubts that a drug that extends lifespan but does not target a specific recognized disease could be approved for sale in the world’s most lucrative pharmaceutical market. The FDA through regulatory guidance – or Congress through legislative action – could lay that concern to rest.

But even with the promise of market exclusivity beyond the end of the twenty-year patent life, and even with assurance that the FDA would approve an effective antiaging drug, large pharmaceutical companies still may balk at R&D efforts that won’t affect quarterly earnings in the short to medium term. Likewise, biotech startups may steer away from projects that won’t come to fruition before venture capital funding runs out. These concerns about short-termism motivate a search for institutions beyond the pharmaceutical and biotech sectors that might facilitate investment in longevity research.

16.2.2 Nonprofits and Pet Projects

The first stop on that search is an institution with a long history of financing ambitious public health investments: the philanthropic foundation. Millionaire and billionaire philanthropists who fund foundations would seem to have more of an incentive to invest in longevity research than in solving most other public health problems. After all, while many global public health challenges (e.g., malaria and tuberculosis) are unlikely to affect millionaires and billionaires, extreme wealth is no cure for aging. Foundations, moreover, can operate on a longer time frame than publicly traded corporations that must report quarterly earnings, or startups burning through their venture capital funding. Longevity research, with its high risks and long timelines, would seem to be exactly the sort of area in which foundations can play a productive role.

Some foundations have indeed emerged as major funders of longevity research. One of the most famous cases in the law of philanthropy – mentioned in almost every nonprofit law casebook – even has a longevity twist. In re Estate of Buck, described at the time as the “Super Bowl of probate,”Footnote 15 involved the will of Beryl Buck, a long-time resident of wealthy Marin County outside San Francisco. Buck’s will established a charitable trust – a private foundation for tax purposes – that was to be used entirely for nonprofit activities in Marin. Buck funded the trust with oil company stock that traded for less than $10 million at the time of her death but ballooned in value to more than $250 million a few years later.

Reasoning that Buck’s largesse exceeded Marin County’s needs, the San Francisco Foundation – Buck’s designated trustee – sought permission from a California probate court to distribute trust income across the Bay Area. The court rebuffed the foundation’s request, ordering instead that funds be allocated to Marin-based projects with the potential to benefit “all of humankind.” One of these, in northern Marin County, is now named the Buck Institute for Research on Aging and provides a home to a world-class faculty of academic scientists searching for cures to age-related diseases.

Yet foundations like the Buck Trust are unlikely to fill the void left by industry underinvestment in longevity research. Foundation funding is often contingent upon the whims of millionaires and billionaires whose moneymaking skills in one sector – or whose luck in the birth lottery – may not necessarily qualify them as biomedical grantmakers. While perpetual trusts like Buck’s may provide sustained support, other foundations – especially those with living donors – can be more mercurial. A case in point is the Ellison Medical Foundation, financed by Oracle cofounder Larry Ellison, which spent more than $300 million on antiaging research before Ellison abruptly halted further funding in 2013.Footnote 16 Moreover, the aggregate amount of foundation funding for biomedical research remains just a drop in the bucket relative to industry and public sector sources – only around 1 percent of total US biomedical research spending, compared to 66 percent from industry and 25 percent from the federal government.Footnote 17

In recent years, another private sector source has emerged as a much more significant funder of longevity research – at least in dollar terms – than any philanthropic foundation: Alphabet, the parent company of Google. Since 2014, Alphabet has committed $1.75 billion to Calico Life Sciences, an internal laboratory focused on longevity. This is a startling sum for a for-profit company to spend on R&D unrelated to its core business. Yet it represents less than 0.1 percent of Alphabet’s market capitalization as of this writing.

Alphabet has faced criticism for pursuing what seems like a distraction from its profit-generating activities.Footnote 18 But Alphabet’s dual-class corporate structure shields the company from investor pressure. Cofounders Larry Page and Sergey Brin control more than 50 percent of Alphabet’s voting power, even though they own only a little more than one-tenth of the corporation’s stock by value. This dual-class structure would seem to encourage pet projects like Calico, because the cofounders who effectively decide whether to pursue the projects bear only a fraction of the cost.

Nevertheless, mega-corporations like Alphabet are no more likely than philanthropic foundations to bring about century-long lives. For one thing, laboratories inside mega-corporations are vulnerable to their own pathologies. Biomedical researchers outside Calico have described Alphabet’s longevity lab as “hyper secretive” – a clandestinity consistent with the competitive corporate culture of Silicon Valley but at odds with the values of academic science.Footnote 19 For another, Alphabet’s $1.75 billion commitment – though beyond the means of all but the wealthiest private foundations – still pales in comparison to the more than $100 billion that the biopharmaceutical industry spends on R&D each year. Alphabet no doubt has the resources to up its commitment, but at some point – notwithstanding the insulation provided by a dual-class share structure – forces inside and outside the corporation (e.g., independent directors and institutional shareholders) would likely push back if Alphabet allocated substantially more money to a research effort so far afield from the company’s core competencies.

Thus, even in a “second Gilded Age” of billionaire philanthropy and trillion-dollar mega-corporations, we cannot rely exclusively on the private sector to lead us down the path to century-long lives. By far, the entity with the greatest ability to finance longevity research – perhaps the only hope for investment on the requisite scale – remains the US federal government. The prospects for the 100-year life thus depend, in large part, on the political economy of public sector investment in longevity. Encouragingly, the US has a history of financing large-scale R&D efforts – the Apollo project being the most famous example. But as this chapter’s final section highlights, the political landscape for the 100-year life is far less inviting than it was for the original moonshot.

16.3 The Political Economy of the 100-Year Life

Each year Congress plows tens of billions of dollars into biomedical research – with $47.5 billion budgeted for the National Institutes of Health (NIH) in fiscal year 2023. Yet only a tiny sliver of that sum – $405 million – goes toward the Division of Aging Biology (DAB), the unit within NIH’s National Institute on Aging that studies interventions that might slow the aging process.Footnote 20 (The bulk of the National Institute on Aging budget goes toward Alzheimer’s disease and related dementias.) To put the DAB figure in perspective, NIH now spends more each year on research related to brain cancer than the DAB’s entire budget, even though brain cancer affects 0.1 percent of the population while aging ultimately affects everyone.Footnote 21

In recent years, several scientists and public health advocates have argued for a dramatic increase in federal funding for longevity research – a “longevity moonshot.”Footnote 22 They argue that sustained federal investment – on the order of $3 billion annually – will produce long-lasting health and economic gains that compensate for the cost many times over. As the DAB funding figures illustrate, this argument has yet to win over congressional appropriators. Why not?

A partial answer is that the push for a longevity moonshot defies the logic of collective action. As economist Mancur Olson famously observed, small groups with well-defined memberships enjoy political advantages vis-à-vis larger and more diffuse groups: they are better able to forge common identities and less vulnerable to free-riding.Footnote 23 The success of rare-disease patient groups in securing federal funding for orphan drug research is arguably an illustration of the Olsonian logic: Relatively small groups of rare-disease patients have large individual stakes in finding a treatment or cure – and often strong group identities borne out of a shared experience. By contrast, individuals experiencing the aging process are the ultimate large group: Everyone is included.

Beyond the large-group problem, proponents of a moonshot investment in delayed aging face a fiscal challenge. Although the $3 billion-per-year outlay proposed by moonshot advocates would have only a trivial effect on the federal government’s fiscal position, the effort would – if successful in lengthening lifespans – lead to a significant increase in the number of people eligible for old-age entitlement programs such as Social Security and Medicare. Some of the corresponding fiscal burden could be offset by additional tax revenues from older workers who remain in the labor force for longer, as well as from a reduction in per-capita Medicare costs among healthier seniors. Yet economist Dana Goldman and coauthors have projected that even with those offsets, an increase in life expectancy of 2.2 years due to delayed aging would add nearly $420 billion to the federal entitlement deficit by 2060.Footnote 24 The life expectancy gains envisioned by CDRV – twenty years over the course of a century – would place an even greater burden on Social Security and Medicare.

Economically the US could very likely bear the additional fiscal weight of an older but healthier population. For example, Goldman and coauthors estimate that raising the Social Security normal retirement age and the Medicare eligibility age to sixty-eight would more than offset the additional entitlement program costs of delayed aging. But as demonstrated by the recent experience in France – where President Emmanuel Macron’s increase in the retirement age from sixty-two to sixty-four sparked nationwide strikes – retirement age changes remain “the third rail” of politics across the high-income world. An alternative way to offset rising entitlement program costs would be to raise taxes, but both major political parties in the US have soured on broad-based tax hikes in recent years. Most Republican lawmakers have pledged not to vote for any net tax increase, while Democratic President Joe Biden has promised not to raise taxes on any household earning less than $400,000 annually – a promise that puts three-quarters of the income tax base beyond reach.

To be sure, the entitlement spending effects of longer lifespans will accrete slowly, with most of the expenditures lying decades down the road. By then, most of today’s elected officials will have long since retired, died, or been ousted by voters. In that respect, political short-termism – unlike corporate short-termism – may be complementary to longer lifespans: Lawmakers can appropriate more funds to a longevity moonshot while externalizing the difficult fiscal choices to their successors.

But even if the extra entitlement spending triggered by longer lifespans won’t come due for decades, government debt markets may transform those future liabilities into near-term costs. As the US proceeds down a fiscally unsustainable path, investors are likely to demand higher interest rates on Treasury bonds. For that reason, today’s lawmakers may be reluctant to commit to a longevity moonshot that – without unpopular entitlement reforms or tax hikes – will force the federal government to face higher near-term debt service expenses.

This is where the science fiction and the political fiction of the 100-year life converge. The Olsonian logic of collective action is not an iron law: Advocates for programs with diffuse benefits sometimes prevail in the hurly burly of distributional politics. But to do so, proponents of a longevity moonshot will need to weave a narrative that motivates legislators to allocate funds toward longevity research. In other words, the biomedical advances needed to normalize century-long lifespans will likely depend on political developments that require storytelling and imagination.

This political-fiction framing flips Gratton and Scott’s script. Gratton and Scott tell us that the 100-year life is coming, and they argue that policy needs to adapt to that reality. But whether the 100-year life becomes a reality depends in large part on whether longevity moonshot advocates can convince lawmakers and voters that century-long lifespans are worth pursuing. That persuasion effort involves many of the same elements as Gratton and Scott’s adaptation effort: thinking about how different elements of law and society might respond to century-long lifespans and considering whether those responses would leave us better off or worse. But at the end of the day, whether we proceed down the path to a 100-year life remains a political choice, not a fait accompli.

The science fiction and political fiction aspects of the 100-year life merge in another respect: Mapping out the plausible biomedical pathways to century-long lifespans will help us understand what collateral benefits a longevity moonshot might bring. The original moonshot and other NASA space exploration efforts have generated a long list of spinoff technologies ranging from the programmable cardiac pacemaker to the modern cochlear implant. A longevity moonshot may likewise yield collateral biomedical benefits. For example, research on intermittent fasting may yield glycemic control benefits for Type 2 diabetes patients.Footnote 25 Senolytic therapies that delay or reverse aging may help address frailty among childhood cancer survivors.Footnote 26 By highlighting these and other potential payoffs, longevity moonshot proponents may be able to forge political alliances with advocates for disease-specific research, who – for Olsonian reasons – tend to be better organized and more easily mobilized.

In short, understanding the 100-year life as an aspiration rather than an inevitability may make the outcome more realistic. Our legal and political institutions can help to provide the support that makes scientific breakthroughs more likely, but first, advocates will need to convince lawmakers that a longevity moonshot justifies the financial and political costs. Thus, to say that the 100-year life is a work of science fiction, legal fiction, and political fiction is not to write off the possibility of century-long lifespans. Rather, it is to say that in order to achieve the 100-year life, we need to imagine it first. In that sense, the enterprise that Gratton and Scott ask us to engage in is worthwhile even though – indeed, precisely because – century-long lifespans cannot be taken for granted.

17 Bioethics, Reproduction, and Extending Life

This chapter considers where law and bioethics intersect as to the 100-year life. It tackles two different issues. The first is an exploration of the bioethics of life extension and whether such extension is something that should be pursued. The second considers attempts to extend reproduction into the late period of life and the ethics thereof.

17.1 The Bioethics of Life Extension: Should We Do It?

In bioethics it is commonplace, albeit not without its critics, to distinguish treatment from enhancement. Treatments – whether curative (e.g., antibiotics for a bacteria), ameliorative (albuterol for asthmatic episodes), palliative (e.g., morphine for someone in pain in their final days before death), or preventative (vaccination for mumps) – are fully and uncontroversially consistent with the ends of medicine. Enhancements, by contrast, are viewed by some with more suspicion as either things to be prohibited or at least not subsidized by the state.

The political philosopher Norman Daniels is one of the most cogent defenders of the line, which he demarcates around the idea of “species-typical” functioning – that is, an enhancement is what boosts our capabilities beyond a species-typical level of normal functioning, while a treatment corrects for a disease, which is defined as a function of our biology or psychology that reduces an individual below a level of normal functioning.Footnote 1

The pursuit of the 100-year-old life and beyond, especially one that seeks to increase not only the lifespan but also the wellspan and enables longevity and excellent functioning, puts pressure on the treatment enhancement distinction’s attractiveness as a guide either for what individuals should be allowed to pursue on their own (i.e., what should not be prohibited by a society), or what we are owed by the state (the way Daniels primarily employs the distinction). Put simply, living beyond 100 today at the wellness and functioning level of, say, a sixty-year-old is highly species-atypical – experienced by very few, if any. As such, under the Daniels definition it would clearly be an enhancement not a treatment. For some, that would be a reason to prohibit it (such as prohibiting attempts to improve IQ) or exclude it from the health care a society is obliged to provide (or at least unless and until it has met the needs for treatments of disease fully, it is a sort of “bonus”).

That perspective is in tension with many authors of this book and, I would suspect, the majority of the polity, who think pursuing excellent health past 100 is not only permissible but also desirable (possibly even obligatory) for the state to invest in. How to explain this divergence? An “error theory” approach would suggest either that it is a mistake to pursue the 100-year life as all-things-considered justified or that it is the enhancement treatment distinction as a guide for wise public policy that is the error.

In my view, the latter holds. The enhancement treatment distinction seems problematic at least as applied to lifespan and wellspan extension. The distinction seems to trade on a “baseline problem” that confuses is and ought. Consider the way the human lifespan and wellspan have varied dramatically across time. If 200 years ago someone proposed medical interventions to extend our lives by decades to their present length and wellness, would we have been right to resist those interventions as enhancements?

One might retort that there is a distinction between raising more people to the highest level attainable by our species and going beyond that level.Footnote 2 If we pursued lifespans of 200 years, for example, we would cease being human and become something quite different. At best, the objection is making a problematically undefended appeal to the natural (in this case, what is natural for a human person). Even if we can agree that some things are natural and some are not, there is “no factual reason to suppose that what is natural is good (or at least better) and what is unnatural is bad (or at least worse).”Footnote 3 As Frances Kamm puts it:

The assumption behind [this view] is that nature is sacred and should be honored. But why should we believe this? Cancer cells, AIDS, tornadoes, and poisons are all parts of nature. Are they sacred and to be honored? The natural and the good are distinct conceptual categories and the two can diverge: the natural can fail to be good and the good can be unnatural (e.g., art, dams, etc.). Suppose nature was sacred and to be honored. We would clearly be overriding its dictates by making people able to resist (by immunization) illnesses that they could not naturally resist. Is doing this impermissible because it does not honor nature? Surely not.Footnote 4

Of course, rejecting the treatment enhancement line or appeals to the natural does not guarantee that a particular “enhancement” (if you must use that word) is unobjectionable. But increasing the number of years of healthy life escapes many of the stock objections to “enhancements.”

Additional healthy years are more absolute than positional goods,Footnote 5 and as such we are less worried about individuals pursuing them to produce private benefit at externalized costs.Footnote 6 If the project aims at reducing the gap between wellspan and lifespan, there is a plausible argument that it generates significant positive externalities in healthcare spending rates given the fact that healthcare spending currently increases substantially with age.Footnote 7 By contrast, increasing lifespan without correspondingly increasing the wellspan would produce significant cost externalities in terms of healthcare spending.Footnote 8

Some object to enhancements done on children or others as violating a “right to an open future” – that children should be “permitted to reach maturity with as many open options, opportunities, and advantages as possible.”Footnote 9 Even if you are persuaded in general by this objection,Footnote 10 when lifespan and wellspan expand in tandem it is hard to see the extension as deeply limiting rights to an open future. If anything, the number of “futures” one might pursue seem to expand in that one could imagine fourth or fifth careers, marriages, and so on, with a long-enough healthy life.

A different objection is about the irreversibility of some enhancements – especially when imposed on those who do not yet exist but, because of irreversibility, are stuck with them.Footnote 11 There is a sensitive question about when life extension counts as “irreversible.” One could seek to end one’s life, and there is an argument that in a world of longer life spans there would be an obligation to also provide more end-of-life options. But ending one’s life is not a “reversal” of healthy longevity. It is the cessation of a life of a being who has been enhanced to live much longer. A “natural death” (whatever that means) becomes available only if one “sticks it out” – can we consider that a kind of injury that cannot be reversed? Without resort to a problematic baseline or undefended appeals to the natural it may be hard to characterize this as a deep problem with life extension; if this is a problem to impose on our children, so is our imposition of disease-free (or disease-reduced) lives for our children right now – they too cannot easily be “reversed.”

A different objection is what I have elsewhere called “The Coercion of Voluntary Enhancements (not Oxymoronic!).”Footnote 12 Imagine the extension of lifespan and wellspan were completely optional – individuals could choose it or not without state penalty. Let’s further assume the extension is completely state-subsidized or otherwise costless (see below regarding the effect of relaxing this assumption). While this seems like a victory, as with all voluntary enhancements, there is a concern that it will result in “a new equilibrium where everyone enhances, or at least many choose to enhance who would not choose to enhance but-for the need to compete with the enhanced in a zero-sum distribution, and those who fail to enhance will suffer in terms of the distribution.”Footnote 13

With increased lifespan and wellspan it is easy to see how this will work. Why should law school only last three years, or medical school four? Why shouldn’t a thirty-year mortgage be extended by years or decades given longer life? Even if we imagine that each of these changes are, on balance, good, there is a distributional effect: Those who do not extend their lives face more life plans to which they are shut out (or at least delayed entry, with fewer years to experience them) as against a world where the extensions never happen. The end result is that many people who, but for this dynamic, would not choose to extend their (or their child’s) life will now do so. Furthermore, the “exit” options of ending one’s life will not solve the problem since the dynamic produces a “delayed start” in access to life plans.

I am fully convinced this is a real dynamic we would see if wellspan and lifespan are extended. But is it a moral problem? One answer is to say it is a problem, but not a problem for the “enhancement.” That is, we should strive to have our cake and eat it too – enabling life extension while seeking to correct this dynamic through other means such as labor law, antidiscrimination law (which must now protect the young more than in the past), forced retirements, and so on. Alternately, we could disagree that this is a problem, or at least a serious one. In prior work I have explored this with a hypothetical about a safe and costless drug that would improve the safety of airplane pilots and wondered whether we should be sympathetic to a pilot who argues “I have a right not to enhance and improve the safety of passengers, and the fact that it makes me a worse pilot and makes it more likely that my plane will crash, should not count against me in competing for this job.”Footnote 14

The pilot case – like all cases – has a mix of absolute and positional benefits skewing toward the absolute. Is the same true of life extension? Moreover, part of the “intuition pump” of this example is set up by assuming that the drug is safe and improves pilot performance significantly. This suggests that one may not make a judgment about life extension and the “voluntary coercion” effect as a whole but, instead, one might need to go institution by institution to determine whether requiring more experience as a condition of entry in a particular case is “credential inflation” without offsetting benefit or not.

One final relevant objection to enhancements is that when an enhancement becomes available it causes us to lose solidarity with those who choose not to avail themselves of it, including by shifting responsibility to them for bad health states. As framed by Michael Sandel, the more we come to view our lives as chance not choice, the more reason we have to share our fate with others, including through public financial support. However, all that might wither with enhancement.Footnote 15 Those who live for a very long time might come to view those with normal (as of 2023) lifespans and wellspans as poor unfortunate souls, the human equivalent of mayflies (who live for only a day), or perhaps as something quite different from ourselves, to whom we stand in the same distant relationship as to an unknown “beggar in Spain,” to borrow Nancy Kress’s novel’s title.Footnote 16 It is possible to contest the descriptive claim – to note that extending wellspan, in particular, might open more resources to all; to carve out the cases of failure to enhance children as one where the dynamic is least likely to hold; or to contest that our obligations to help others meet their health needs ought not to be premised on responsibility-based arguments.Footnote 17 One might also choose to “bite the bullet” and argue that, at least regarding wellspan extension, we ought to heap scorn or otherwise pressure others to engage in enhancement.Footnote 18 Still the possibility that life and wellspan extensions might create a genetic overclass and underclass is worrying and a reason why it is essential for the state, if possible, to try to equalize access to this extra time lest it become one more way of achieving hierarchy – especially dynastic.Footnote 19

Resources, though, are not infinite. Is it appropriate for the state to spend resources (such as grant funding) on extending the lifespan of those who already live fairly healthily into their seventies and eighties given how many people fail to live even that long or whose shorter lifespan is plagued by illness? One’s commitment to particular theories of distribution will shape the reply; utilitarianism, prioritarianism, and sufficientarianism offer well-established answers regarding what counts as a just distribution. Each of these theories can be applied to allocating “life years” or “health life years” and will provide different answers to when it is appropriate for the state to make the “rich” (in terms of years or health life) richer as opposed to focusing (or at least first focusing) efforts on the “poor.” There is also well-developed, if perhaps not resolved, literature in the space of rationing scarce medical goods (such as organs, vaccines, ICU beds) debating when it is appropriate to engage in “age weighting” – giving priority to younger over older claimants all else being equal, with one of the central arguments being the need to give everyone “fair innings” – a requisite number of life years to enable a particular kind of life.Footnote 20 Many of the same concepts are applicable if we were allocating life extension directly rather than having it as an output of one of these other scarce goods. To the extent the relevant resources (e.g., research funding) were fungible, on many plausible theories the state would only be justified in pursuing or promoting life extension once it had already satisfied its duties toward those who currently receive lives that are unfairly short.

17.2 Fertile Octogenarians Abound! Reproducing Late in Extended Lives

As some may remember dimly from their property law class (or – in my case –studying for the bar) there is a funny pitfall in the application of the classic Rule Against Perpetuities to trusts that goes by the name of the “fertile octogenarian” rule, stemming from “a conclusive presumption of lifetime fertility.”Footnote 21 While at one point reproducing in one’s eighties – for women at least – was a fanciful law school hypothetical, in fact it is very possible today. What would it mean to reproduce late in the 100-year life?

The oldest reported successful pregnancy I know was of a seventy-three- or seventy-four-year-old woman (depending on the report) in India, who gave birth to twins by caesarean section.Footnote 22 But, of course, in “collaborative” or “third-party” reproduction the person seeking to produce a child to rear need not carry the child to term and may instead use a gestational surrogate. Many couples fertilize additional embryos as part of in vitro fertilization (IVF) and cryopreserve (i.e., “freeze”) them for a potential future use. In 2017, it was estimated that about 1 million embryos were housed in subzero facilities in the US alone.Footnote 23 One could imagine a case where a couple fertilizes seven embryos at age thirty and implants them one at the time, leading to a successful pregnancy and the birth of a boy. Fifty years later they decide they want another child and then find a surrogate willing to assist. After paying her and thawing and transferring one of their cryopreserved embryos, there is a successful pregnancy and the birth of a girl. This girl would be fifty years younger than her full genetic brother in terms of her chronological age, but, if viewed from the moment of fertilization, she would be the exact same age as that brother – a strange incongruence.

This thought experiment is not that fanciful: in 2020 a child was born from a donated embryo frozen on October 14, 1992 and thawed for implantation in February 2020.Footnote 24 The embryo was successfully transferred to and carried by Tina Gibson, who would serve as its legal and rearing mother – she herself was two years old when the embryo was first created.Footnote 25 At twenty-seven years this is the current record for freezing and thawing, but there is no reason to think it could not go longer.

There are many other ways that reproduction so late in life could occur – frozen eggs, posthumously retrieved sperm, or perhaps most simply for older men with younger female partners. For example, James Doohan, who played “Scotty” on the original Star Trek, apparently had a daughter when he was aged eighty with his forty-four-year-old wife without intending to conceive.Footnote 26

New technologies might provide still further extension of our reproductive periods. Mitochondrial replacement technique (MRT, sometimes called “three-parent IVF” by the lay press) is one “that involves removing an intended mother’s [nuclear] DNA from her oocyte [egg] or zygote, which contains mutated [mitochondrial] DNA, and transferring it into a female provider’s oocyte or zygote, which contains nonpathogenic [mitochondrial] DNA and from which the [nuclear] DNA has been removed.”Footnote 27 While MRT’s primary use, and the use to which it has been authorized in the UK and a few other countries, has been to avoid transmitting mutant mitochondrial DNA to offspring while maintaining a mother’s genetic tie to the child,Footnote 28 there have also been discussions of using it as a way to “rejuvenate” the eggs of older mothers.Footnote 29 In vitro gametogenesis (IVG) in lay terms refers to deriving sperm or egg from a human’s adult cells – for example, skin cells.Footnote 30 While the technique has thus far only been used to produce offspring in nonhuman animals, there is significant interest in many human applications of IVG, including as a way of enabling older women to produce eggs for reproduction.Footnote 31

Becoming a biological parent so late in life raises a host of interesting issues that stretch across many private and public law areas, including trust and estates, family law, insurance law, and public benefits law. I will not do any of it justice in this short space, but instead want to connect “reproducing so late in life” to two more general debates about the ethics of reproduction that I have written on: the rights claim to reproduce (especially as to state support for reproduction), which I will discuss in some depth, and claims of harm to offspring, which I will touch on only briefly.

In a recent paper on uterus transplants (currently used for women with uterine factor infertility, but in the future potentially for those assigned male at birth), I drew a distinction between the “first wave” of reproductive technologies “encompassing everything from Artificial Insemination to In Vitro Fertilization (IVF), Surrogacy, and Preimplantation Genetic Diagnosis (PGD)” and a new wave that encompasses uterus transplants, MRT, IVG, and potentially egg-freezing.Footnote 32 The first wave “focused on restoring or enabling the kind of reproductive options available to fertile, heterosexual, couples, a focus on what I call ‘mimicking’” and thus “largely expanded access to that which could be achieved by traditional reproduction.”Footnote 33 The new wave, by contrast, is “more focused on ‘extending’ reproduction beyond what is possible through sexual reproduction.”Footnote 34 The mimic extender distinction is interrelated to distinctions others have drawn in the literature:

[Lisa Ikemoto distinguishes] between fertile, medically infertile, and “dysfertile” individuals. Ikemoto defines the dysfertile as “those rendered childless by their failure to fit the definition of infertile, because they are unmarried and/or lesbian or gay.” I would expand the category slightly to include all individuals who have no medical limitation to their fertility but instead face an obstacle towards their reproduction.Footnote 35

The rights claim of a hypothetical ninety-year-old woman who wants to use one or more of the technologies discussed above to reproduce so late in life seems to be an extension, and not mimic use. The extension-mimic line seems normatively attractive in part because it mirrors the distinction between treatment versus enhancement discussed earlier.

Those defending such a line claim the state has an obligation to permit (and perhaps fund) medical interventions that seek to restore individuals into the range of species-typical normal functioning (treatment), whereas there is no obligation to permit (and certainly no obligation to fund) that which allows individuals to exceed that range (enhancement). This is connected … to a conception of health and why the state has a role in promoting it, namely, as a way of furthering the larger goal of ensuring that all have access to the “normal opportunity range” that is “the array of life plans reasonable persons are likely to develop for themselves.” Extenders are seeking things that are clearly species atypical, and the case of men using uterus transplants is a good illustration of that.Footnote 36

The same might apply to our hypothetical ninety-year-old woman: She is asking for something species-atypical. While that fact may not justify a negative liberty restriction – I return to harm-based arguments that would be more common reasons for such restrictions later – does it defeat her rights claim to positive liberty state support for such reproduction?Footnote 37

One response to this suggestion is to reject a keying of the treatment enhancement line to the conception of species-typical normal functioning, but then one needs another way to distinguish claims to assistance for health needs (with the moral urgency we normally assign to it) from nonhealth needs. A more radical approach would be to reject views that assign a special importance to health in favor of more consequentialist theories that

may discard “health” as an intermediate concept to some extent; that is, it does not matter whether [the intervention] advances “health” or a nonhealth interest of the individual. What matters is how much it advances that welfare interest and at what cost … On such views, if we ask, “Yes, but is it a health care intervention?” we ask that question not because it matters as a first-order matter, but because we have ministerially divided the world of what the government pays for into buckets, and we are asking whether this should come out of the health care bucket.Footnote 38

A third response is from within the species-typical normal functioning approach and suggests we may be too quick to assume that a woman’s reproduction at ninety is not species-typical. It is, after all, species-typical for men to be able to reproduce quite late in life like Star Trek’s Scotty did. Why is the right “comparator” group for species typicality the “female of the species” and not “the species, sex unspecified”?Footnote 39

Another possible rejoinder is that while reproduction so late in life is species-atypical for a kind of organism that lives till eighty, it would not be atypical for a species that lived so much longer than that. For someone likely to live to age 200 reproducing at age ninety is roughly at the same point in one’s lifespan as it would be for someone likely to live to eighty to reproduce at age thirty-six – and we would view that as quite normal. Why not view the species-typical question in terms of proportions of a life-span – that is, it remains “species typical” to reproduce in the first third to half of one’s life span, with a third or a half being much longer with life extension?

For me there is a bit of a bootstrap “hat on a hat” quality to this argument: It suggests that once we have permitted the enhancement that enables individuals to live a much longer life (see Part I), our expectation of what is species-typical would reset – thus treating reproduction so much later in life as typical. On the other hand, when our range of lifespan or wellspan extends so much longer, why should our idea of a normatively tinged “normal opportunity range” not extend commensurately?

This move might generate the following countermove: There is an old maxim in the law of equity that “equity aids the vigilant, not those who slumber on their rights.”Footnote 40 Those making a rights claim to use reproductive technologies at age ninety have, like Rip Van Winkle, slept an awful long time on their reproductive capacities. Does that suggest their claim to state assistance is forfeit or at least much diminished? Is it discriminatory against older individuals to deny them state support for opportunities not because they are older or is the fault theirs in failing to take advantage of an opportunity available to them when they were younger? Some might find that such a framing of formal equality misses the point. After all, one might use the same logic as to state support for women given our current lifespans: that the state can justifiably deny women past age thirty-eight state support for IVF in that they too slept on their rights – a right to reproduce earlier without the need of such technology. This feels like a reductio ad absurdum, especially when one considers how a society that refuses to support reproduction after age thirty-eight fosters a widening gap of sex inequality since it is women whose health and professional lives are most burdened by pregnancy.

On the flipside, though, state support of reproduction quite late in life might lead to a different kind of inequality through the dynamic of “voluntary coercion” of enhancements discussed earlier. Those who decide to extend their lives and have the resources to do so might feel the need to delay their reproduction to give themselves or their child the best start in life from a resource perspective. Some will simply not be able to afford the technologies needed to delay reproduction. Others who can afford it but would rather not reproduce so late may feel pressure to do so for their children to compete in a zero-sum society.

From the admitted (science fiction) armchair, it is a little hard to predict if this dynamic would take hold. So long as our ability to extend life or wellspan has a stopping point, one might argue that the pressure to delay reproduction is countered by the reality that every year of delay is one fewer year to spend with the child one produces. The equilibrium that results from trade-offs between enjoying one’s life without children, furthering one’s own non–child-rearing goals, building resources to give one’s children an excellent life, the number of years of life people would prefer to share with their children (and countless other factors) is hard to predict. So much seems likely to be mediated by culture that it seems like a shot in the dark to guess people’s first-order preferences.

While we started with the mimic-extension line, we have found both normative uncertainties about the moral force of species typicality and its underlying architecture of the normal opportunity range to this question, as well as difficulty predicting how extending lifespan would affect individuals’ reproductive choices if reproducing much later in life was also possible. One seemingly potential way out might be – in the positive liberty and even the negative liberty sense – to set policy based on the idea that reproduction so late in light is harmful to children.

The problem is twofold. One part is descriptive – how sure are we that reproduction late in life is bad for offspring? Over the past couple of decades, several jurisdictions – including France, Greece, Italy, Japan, and some Australian states – have at various points had in place prohibitions on IVF for women above a certain age premised on concern for the welfare of offspring.Footnote 41 It is important to distinguish risk to offspring from risk to pregnant persons (including the risk of losing the pregnancy). A recent review article summarized the existing state of the literature:

Advanced maternal age is associated with a wide range of risks for adverse perinatal outcomes, although the magnitude of risk for most outcomes is small. The risks are strongest for early miscarriage, late miscarriage and chromosomal abnormalities. There are weaker associations with stillbirth, FGR, PTB, pre-eclampsia, GDM and CS, not all of which rise to the level of clinical significance.Footnote 42

Whether these problems would become worse, improve, or stay the same in individuals whose life was radically extended will certainly depend on how life extension is achieved. But it seems plausible that some but not all of those risks might be mitigated by permitting reproduction but not pregnancy very late in life. Such a strategy would require increased use of gestational surrogacy, which for some may be a normative reason to oppose it. But the normative justification of prohibition on this basis would be explicitly paternalistic (harm to self) rather than offspring-focused (harm to others), the latter being a more common basis for reproductive regulation.Footnote 43

What about risk to offspring in a possible future where individuals (especially women) can produce gametes much later in life than they currently can? In our current technological attainment, advanced maternal and paternal age has been associated (among other things) with autism spectrum disorders in children – with the most frequently cited hypothesized mechanisms on the paternal side being “increased rates of de novo mutations and epigenetic alternations associated with increasing age,” and on the maternal side being “higher rates of chromosomal abnormalities, perinatal and obstetric complications, and potential genomic and/or epigenetic alterations induced by cumulative exposure to environmental toxins.”Footnote 44 If these trends persist with radical life extension and reproduction even late in life, are these the kinds of deficits that should matter to that state? Or does such an intervention impermissibly favor the neurotypical over the neurodiverse in a way that should be intolerable from a disability rights perspective? A different set of arguments surrounds the harm to a child from being born to parents who will be deceased early on in that child’s life – in fact, this is an area where life extension might be a solution rather than part of the problem.

But even if one resolves these kinds of questions in favor of the view that the risks to offspring are so great that they would justify prohibition on reproduction late in life, there is a second more conceptual problem associated with Derek Parfit’s non-identity problem:Footnote 45 We cannot justify prohibiting an act of reproduction on the basis of harm to the offspring that would result (what I have called “best interests of the resulting child” justifications) if we provide the child a life worth living, because that child’s existence is not worse than a counterfactual of not existing at all. As I wrote more than a decade ago:

The easiest version of the problem to see involves regulation of whether individuals reproduce, for example, the denials of access to reproductive technology to gay, aged, or single parents. Imagine that sixty-year-old Ethel wants to have a baby through reproductive technology and assume arguendo that this child, Maxwell, will be worse off (physiologically, psychologically, etc.) than would the average child born to a woman in her twenties. We cannot say that a state law preventing Ethel’s access to reproductive technology at her age furthers the welfare of Maxwell, because if the State blocks that access Maxwell will never exist and, so long as he has a life worth living, coming into existence does not harm him.Footnote 46

My claim remains controversial among both philosophers and legal scholars.Footnote 47 Even if accepted, this does not rule other arguments for prohibiting reproduction by aged parents for which the welfare states of offspring may be relevant: arguments premised on non–person-affecting principles, wronging without harming, reproductive externalities, virtue ethics – or arguments premised on legal moralism, or justified paternalism, and perhaps other arguments might still be available.Footnote 48 But to justify age-based regulation of reproduction on one of these grounds is more fraught, normatively speaking, than relying on the much simpler harm principle-type argument I believe is illusory in this space. These alternative arguments often have premises or entailments that some will find problematic and require us to step outside of the more comfortable liberal commitment to child welfare as a north star.Footnote 49

Footnotes

13 The 100-Year-Old American and Our Health System

1 U.S. Health Care from a Global Perspective, 2022: Accelerating Spending, Worsening Outcomes, Commonwealth Fund (Jan. 31, 2023), https://www.commonwealthfund.org/publications/issue-briefs/2023/jan/us-health-care-global-perspective-2022.

2 Dayna Bowen Matthew, Just Health: Treating Structural Racism to Heal America 4–13, 33–50 (2022).

4 Eileen M. Crimmins, Lifespan and Healthspan: Past, Present, and Promise, 55 Gerontologist 901, 901 (2015).

5 National Academy of Medicine, Global Roadmap for Healthy Longevity 1–5, 221–222 (2022) [hereinafter Global Roadmap].

6 Linda P. Fried, Investing in Health to Create a Third Demographic Dividend, 56 Gerontologist S167, S171 (2016).

7 Institute of Medicine, The Future of Public Health 1, 19 (1988).

8 J. Michael McGinnis & William H. Foege, Actual Causes of Death in the United States, 270 JAMA 2207 (1993); Steven A. Schroeder, We Can Do Better: Improving the Health of the American People, N. Eng. J. Med. 1221 (2007).

9 Inst. of Med., For the Public’s Health: Investing in a Healthier Future 28 (2012) [hereinafter For the Public’s Health].

10 Ano Lobb, Health Care and Social Spending in OECD Nations, 99 Am. J. Pub. Health 1542, 1543 (tbl. 1) (2009).

11 Global Roadmap, supra Footnote note 5, at 14–15, 178–179, 182–191.

12 Footnote Id. at 26–27, 180.

13 Footnote Id. at 184.

14 Vivek H. Murthy, Our Epidemic of Loneliness and Isolation: The U.S. Surgeon General’s Advisory on the Healing Effects of Social Connection and Community, US Dep’t of Health & Hum. Servs. (2023), https://www.hhs.gov/sites/default/files/surgeon-general-social-connection-advisory.pdf.

15 Global Roadmap, supra Footnote note 5, at 180–191.

16 Tiia Ngandu et al., A 2 Year Multidomain Intervention of Diet, Exercise, Cognitive Training, and Vascular Risk Monitoring versus Control to Prevent Cognitive Decline in At-Risk Elderly People (FINGER): A Randomised Controlled Trial, 385 Lancet 2255 (2015).

17 Elodie Passeri, Alzheimer’s Disease: Treatment Strategies and Their Limitations, 23 Int. J. Molecular Sci. 13954 (2022).

18 Lindsay F. Wiley, From Patient Rights to Health Justice: Securing the Public’s Interest in Affordable, High-Quality Health Care, 37 Cardozo L. Rev. 833, 867–871 (2016).

19 For the Public’s Health, supra Footnote note 9, at 21.

20 Joelle H. Fong, Disability Incidence and Functional Decline among Older Adults with Major Chronic Diseases, 19 BMC Geriatrics 323 (2019).

22 Practicing Urologists in the United States 2022, Am. Urological Ass’n 5, 16 (2023), https://www.auanet.org/documents/research/census/State%20Urology%20Workforce%20Practice%20US.pdf.

23 US Dep’t of Health & Hum. Servs., Projections of Supply and Demand for Women’s Health Service Providers: 2018–2030 (2021), at 10, https://bhw.hrsa.gov/sites/default/files/bureau-health-workforce/data-research/projections-supply-demand-2018-2030.pdf.

24 Dorothy Pawluch, The New Pediatrics: A Profession in Transition 31 (1996).

25 Am. Acad. of Pediatrics, 90 Years of Caring for Children, 1930–2020 (2020), at 10–12.

26 Alexandra Minna Stern & Howard Markel, Introduction, in Formative Years: Children’s Health in the United States: 1880–2000, 1, 12 (Alexandra Minna Stern & Howard Markel eds., 2002).

27 Inst. of Med., Retooling for an Aging America: Building the Health Care Workforce 125 (2008) [hereinafter Retooling for an Aging America].

28 Footnote Id. at 123–126.

29 John W. Rowe, Terry Fulmer & Linda P. Fried, Preparing for Better Health and Health Care for an Aging Population, 316 JAMA 1643, 1643 (2016).

30 Neil M. Resnick & Nichole Radulovich, The Relative Value Unit in Academic Geriatrics: Incentive or Impediment? 62 J. Am. Geriatric Soc. 553 (2014).

31 Terry Fulmer et al., Actualizing Better Health and Health Care for Older Adults, 40 Health Aff. 219, 220 (2021).

32 Valarie K. Blake, Regulating Care Robots, 92 Temp. L. Rev. 551, 553, 555 (2020).

33 Retooling for an Aging America, supra Footnote note 27, at 128.

34 The Anti-Ageism Taskforce at the International Longevity Center, Ageism in America (2022), at 71, https://aging.columbia.edu/sites/default/files/Ageism_in_America.pdf [hereinafter Ageism in America].

36 COVID-19 Nursing Home Data, Centers for Medicare & Medicaid Services (Sep. 10, 2023), https://data.cms.gov/covid-19/covid-19-nursing-home-data.

37 Allison K. Hoffman, Reimagining the Risk of Long-Term Care, 16 Yale J. Health Pol’y. L. & Ethics 147, 165–171 (2016).

38 Ageism in America, supra Footnote note 34, at 9.

39 Global Roadmap, supra Footnote note 5, at 205.

40 89 Fed. Reg. 40876, 40879 (2024); Biden-Harris Administration Takes Historic Action to Increase Access to Quality Care, and Support to Families and Care Workers, CMS (Apr. 22, 2024), https://www.cms.gov/newsroom/press-releases/biden-harris-administration-takes-historic-action-increase-access-quality-care-and-support-families.

41 Jordan Rau, Federal Officials Propose New Nursing Home Standards to Increase Staffing, N.Y. Times (Sep. 1, 2023), https://www.nytimes.com/2023/09/01/health/nursing-home-staffing-cms.html.

42 Larisa Antonisse, Strengthening the Right to Medicaid Home and Community-Based Services in the Post-COVID Era, 121 Colum. L. Rev. 1801 (2021).

43 527 U.S. 581 (1999).

44 Nina A. Kohn, Nursing Homes, COVID-19, and the Consequences of Regulatory Failure, 110 Geo. L.J. Online 1, 11 (2021).

45 Linda P. Fried, The Need to Invest in a Public Health System for Older Adults and Longer Lives, Fit for the Next Pandemic, 9 Frontiers in Pub. Health (2021).

46 Social Security and Medicare Boards of Trustees, Status of the Social Security and Medicare Programs: A Summary of the 2023 Annual Reports (2023), at 2.

47 This might result in sequestration under PAYGO (“pay-as-you-go”) rules, which require that new legislation involving mandatory spending “must not increase projected deficits.” The Statutory Pay-As-You-Go Act of 2010: A Description, White House Off. of Mgmt. & Budget, https://obamawhitehouse.archives.gov/omb/paygo_description/#:~:text=2010%3A%20A%20Description-,The%20Statutory%20Pay%2DAs%2DYou%2DGo%20Act%20of%202010,must%20not%20increase%20projected%20deficits (accessed Sep. 26, 2023).

48 Dana P. Goldman et al., The Benefits of Risk Factor Prevention in Americans Aged 51 Years and Older, 99 Rsch. & Practice 2096 (2009).

49 Matt McKillop & Dara Alpert Lieberman, The Impact of Chronic Underfunding on America’s Public Health System: Trends, Risks, and Recommendations (2021), at 8.

50 Inst. of Med., U.S. Health in International Perspective: Shorter Lives, Poorer Health 1–4 (2013).

51 Diane Berish et al., Is There a Woodwork Effect? Addressing a 200-Year Debate on the Impacts of Expanding Community-Based Services, 31 J. Aging & Soc. Policy 85, 94–96 (2019).

52 Charliene Harrington, N. G. Terence & Martin Kitchener, Do Medicaid Home and Community Based Service Waivers Save Money? 30 Home Health Care Services Q. 198 (2011).

53 Lyndon B. Johnson, Remarks with President Truman at the Signing in Independence of the Medicare Bill (July 30, 1965), https://www.presidency.ucsb.edu/documents/remarks-with-president-truman-the-signing-independence-the-medicare-bill.

55 Rachel M. Werner, Allison K. Hoffman & Norma B. Coe, Long-Term Care Policy after COVID-19: Solving the Nursing Home Crisis, 383 N. Eng. J. Med. 903 (2020).

56 Lisa I. Lezzoni, Naomi Gallopyn & Kezia Scales, Historical Mismatch between Home-Based Care Policies and Laws Governing Home Care Workers, 38 Health Aff. 973, 976–977 (2019).

57 Pamela J. Doty, Marie R. Squillace & Edward Kako, Analysis of State Efforts to Comply with Fair Labor Standards Act Protections to Home Care Workers, US Dep’t Health & Hum. Services (Dec. 2019), at 23, https://aspe.hhs.gov/sites/default/files/migrated_legacy_files//193336/FLSAimpl.pdf.

58 Hoffman, supra Footnote note 37.

60 Footnote Id. at 156.

61 Fried, supra Footnote note 6.

62 David E. Bloom, David Canning & Jaypee Sevilla, The Demographic Dividend 39 (2003).

63 Global Roadmap, supra Footnote note 5, at 51–81.

64 Footnote Id. at 72–73.

65 Linda P. Fried et al., Experience Corps: A Dual Trial to Promote the Health of Older Adults and Children’s Academic Success, 36 Contemp. Clin. Trials 1 (2013).

66 Chris Farrell, Retired Doctors Return to Work for COVID-19, Next Avenue (Mar. 27, 2020), https://www.nextavenue.org/retired-doctors-return-to-work-for-covid-19/.

67 Michael Ashley Stein et al., Accommodating Every Body, 81 U. Chi. L. Rev. 689, 755 (2014).

68 Linda P. Fried, A Prescription for the Next Fifty Years of Medicare, 39 Generations 180 (2015).

69 Ramsey Alwin & Lona Choi-Allum, Career Changes Are Becoming More Common with Increased Longevity, AARP Rsch. (Apr. 23, 2020), https://www.aarp.org/pri/topics/work-finances-retirement/employers-workforce/adults-career-journeys.html.

70 Linda P. Fried, Older Women: Health Status, Knowledge, and Behavior, in Women’s Health, The Commonwealth Fund Survey, 175, 177–181, 188–190 (Marilyn M. Falik & Karen Scott Collins eds., 1996).

14 Making the Best of Long-Term Care for Seniors

1 When the Social Security program was enacted in the 1930s, life expectancy was not many years beyond the age to qualify for old-age benefits. As life expectancy increased, Social Security old-age benefit payments also increased, both in total amount and duration. On average, Social Security old-age beneficiaries now expect to receive Social Security benefits for twenty years.

2 The Medicare program includes hospitalization insurance (“Part A”), medical insurance (“Part B”), and prescription drug insurance (“Part D”).

3 Cost of Care Survey, Genworth (June 2, 2022), https://www.genworth.com/aging-and-you/finances/cost-of-care.html.

4 Medicare does not cover LTC generally, but covers up to 100 days of nursing home care after a hospitalization as well as some hospice care and special-needs care.

5 Admin. for Cmty. Living, US Dep’t of Health & Hum. Serv., 2022 Nat’l Strategy to Support Family Caregivers 9 (2022), https://acl.gov/CaregiverStrategy (defining family “in the broadest possible sense” to include everyone with whom the person needing LTC has a relationship bond).

6 Susan C. Reinhard et al., AARP Pub. Policy Inst., Valuing the Invaluable 2019 Update: Charting a Path Forward (2019), https://collections.nlm.nih.gov/catalog/nlm:nlmuid-101767885-pdf [hereinafter Valuing the Invaluable 2019].

7 Susan C. Reinhard et al., AARP Pub. Policy Inst., Valuing the Invaluable 2023 Update: Strengthening Supports for Family Caregivers (2023), https://www.aarp.org/ppi/info-2015/valuing-the-invaluable-2015-update.html (noting $600 billion value of LTC provided by 38 million unpaid caregivers); Valuing the Invaluable 2019, supra Footnote note 6 (estimating that the economic value of unpaid family care was 20 percent of US healthcare costs).

8 Brenda C. Spillman et al., Office of the Assistant Sec’y for Planning & Evaluation, US Dep’t of Health & Hum. Serv., Informal Caregiver Supply and Demographic Changes: Review of the Literature 18, 22 (2020), https://aspe.hhs.gov/pdf-report/informal-caregiver-supply-and-demographic-changes-review-literature [hereinafter Informal Caregiver Supply].

9 Deborah Carr & Rebecca L. Utz, Families in Later Life: A Decade in Review, 82 J. Marriage Fam. 346 (2020).

10 Valuing the Invaluable 2019, supra Footnote note 6.

11 Informal Caregiver Supply, supra Footnote note 8.

12 Arline T. Geronimus, Weathering: The Extraordinary Stress of Ordinary Life in an Unjust Society 10–11 (2023).

13 Sean Fahle & Kathleen McGarry, Women Working Longer: Labor Market Implications of Providing Family Care, in Women Working Longer: Increased Employment at Older Ages, 161 (Claudia Goldin & Lawrence F. Katz eds., 2018).

14 Valuing the Invaluable 2019, supra Footnote note 6.

15 Admin. on Aging, Admin. for Cmty. Living, Dep’t of Health & Human Serv., FY 2016 Rep. to Congress: Older Americans Act 23–24 (2016).

16 Richard W. Johnson et al., Office of the Assistant Sec’y for Planning & Evaluation, US Dep’t of Health & Hum. Serv., Extended LTSS Utilization Makes Older Adults More Reliant on Medicaid 5 (fig. 2) (2021), https://aspe.hhs.gov/pdf-report/extended-ltss-utilization-makes-older-adults-more-reliant-medicaid-issue-brief.

17 Melissa M. Favreault, Urban Inst. Health Policy Ctr., & The Commonwealth Fund, Incorporating Long-Term Services and Supports in Health Care Proposals: Cost and Distributional Considerations (2020), https://www.urban.org/research/publication/incorporating-long-term-services-and-supports-health-care-proposals.

18 Rachel M. Werner et al., Long-Term Care Policy after COVID-19: Solving the Nursing Home Crisis, 383 N. Eng. J. Med. 903 (2020).

19 Robyn I. Stone, LTSS: A Microcosm of Systemic Racism, Leading Age LTSS Center @UMass Boston (Dec. 15, 2020), https://www.ltsscenter.org/ltss-a-microcosm-of-systemic-racism (noting that low pay, physically demanding work, and racial hierarchies in nursing homes make LTC workers of color “subservient,” “leading many workers to tell me over the years that they feel as if they are working ‘on the plantation’”).

20 See Isabel Wilkerson, Caste: The Origins of Our Discontent 132–133 (noting African Americans throughout US history “were relegated to the dirtiest, most demeaning and least desirable jobs … and well into the twentieth century, they were primarily restricted to the role of sharecroppers and servants – domestics”).

21 Olmstead v. L. C., 527 U.S. 581 (1999).

22 Federal funding for state HCBS programs includes Medicaid grants and grants under the Older Americans Act. 42 U.S. Code § 3030(d).

23 See What Medicare Covers, What Part A Covers, What Are My Other Long Term Care Choices? Medicare, https://www.medicare.gov/what-medicare-covers/what-part-a-covers/what-are-my-other-long-term-care-choices#collapse-4912.

24 The LTC cost comparison omits seniors’ housing costs. If a senior does not have access to housing options other than a nursing home, HCBS is not an option.

25 David C. Grabowski, The Cost-Effectiveness of Noninstitutional Long-Term Care Services: Review and Synthesis of the Most Recent Evidence, 63 Med. Care Res. & Rev. 1, 6 (2006).

26 See generally Program of All-Inclusive Care for the Elderly, Medicare, https://www.medicaid.gov/medicaid/long-term-services-supports/program-all-inclusive-care-elderly/index.html.

27 Emily Greenfield et al., A Tale of Two Community Initiatives for Promoting Aging in Place: Similarities and Differences in the National Implementation of NORC Programs and Villages, 53 Gerontologist 928 (2013), https://pubmed.ncbi.nlm.nih.gov/23626371.

28 Steven M. Lieberman et al., Medicare Advantage Enrolls Lower-Spending People, Leading to Large Overpayments (Schaeffer Center White Paper Series, June 2023), https://healthpolicy.usc.edu/wp-content/uploads/2023/06/2023.06_Schaeffer_Center_White_Paper_Role_of_Risk_Adjustment_in_Overpaying_Medicare_Advantage_Plans.pdf (estimating $75 billion of government overpayments to MA plans in 2023 and suggesting MA fee structure reform).

29 The Administration for Community Living (ACL) is a unit of the Administration on Aging (a division of the US Department of Health and Human Services). See About ACL, Admin. for Cmty. Living, https://acl.gov/about-acl/organization. Aging and Disability Resource Centers and Area Agencies on Aging provide information on ACL programs for seniors and family caregivers.

30 See generally US Dep’t of Veterans Affairs, VA Aid and Attendance Benefits and Housebound Allowance, https://www.va.gov/pension/aid-attendance-housebound.

31 See US Dep’t of Veterans Affairs, 2023 VA Pension Rates for Veterans, https://www.va.gov/pension/veterans-pension-rates/#:~:text=What’s%20the%20net%20worth%20limit,Veterans%20Pension%20benefits%20is%20%24150%2C538 ($150,538 net worth limit in 2023).

32 Eric Nordman et al., Ctr. Ins. Pol’y Res., The State of Long-Term Care Insurance: The Market, Its Challenges and Future Innovations (2016), https://nabip.org/media/2654/study-naic-state-of-ltci-may-2016.pdf.

33 See, e.g., Leonard E. Burman, The Perverse Public and Private Finances of Long-Term Care, in Universal Coverage of Long-Term Care in the United States: Can We Get There from Here? 179 (Douglas A. Wolfe & Nancy Folbre eds., 2012).

34 Joan Costa-Font & Nilesh Raut, Long-Term Care Partnership Effects on Medicaid and Private Insurance (CESifo Working Paper No. 9335, 2021), https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3938648.

35 Long-Term Services and Supports Trust Program, H.B. 1087, 66th Leg. Reg. Sess. (Wash. 2019).

36 See generally Marc A. Cohen et al., Learning from New State Initiatives in Financing Long-Term Services and Supports (2020), https://www.ltsscenter.org/wp-content/uploads/2020/07/State-LTSS-Financing-Full-Report-July-2020.pdf (summarizing proposals and legislation in six states).

37 See, e.g., Martha Clare Morris et al., MIND Diet Associated with Reduced Incidence of Alzheimer’s Disease, 11 Alzheimer’s & Dementia 1007 (2015) (Mediterranean diet adherence is associated with 56 percent lower Alzheimer’s risk).

38 Julie Zissimopoulos et al., The Value of Delaying Alzheimer’s Disease Onset, 18 Forum Health Econ. & Pol’y 25 (2014) (concluding “5-year delay [in onset of AD] leads to 2.7 additional life years [and] total [net] value of $511,208 per person”).

15 Immigration and the 100-Year Life

1 Pope: Societies Are Judged by How They Treat Elderly, Who Are an Asset for Young People, Pime Asia News (Nov. 12, 2012), http://www.asianews.it/news-en/Pope:-Societies-are-judged-by-how-they-treat-the-elderly,-who-are-an-asset-for-young-people-26331.html. (Please note that due to space constraints, this chapter is only lightly footnoted.)

2 National Library of Medicine, Providing Healthy and Safe Foods As We Age: Workshop Summary (2010), https://www.ncbi.nlm.nih.gov/books/NBK51841/#:~:text=Only%204.5%20percent%20(about%201.5,million)%20live%20in%20the%20community.

3 OECD, Spending on Long Term Care (2020), https://www.oecd.org/health/health-systems/Spending-on-long-term-care-Brief-November-2020.pdf (the US does not figure in this OECD study on long-term care); Celli Hortsman, Evan D. Gumas & Gretchen Jacobson, U.S. and Global Approaches to Financing Long-Term Care: Understanding the Patchwork, The Commonwealth Fund (2023), https://www.commonwealthfund.org/publications/issue-briefs/2023/feb/us-global-financing-long-term-care-patchwork#:~:text=How%20U.S.%20Long%2DTerm%20Care,out%2Dof%2Dpocket%20spending (the Commonwealth Fund Study makes clear that the US spends a smaller share of its health expenditure on long-term care than other countries).

4 See Hortsman et al., supra Footnote note 3.

5 Howard E. LeWine, Two-Thirds of Seniors Need Help Doing One or More Daily Activities, Harvard Medical School (Dec. 13, 2012), https://www.health.harvard.edu/blog/two-thirds-of-seniors-need-help-doing-one-or-more-daily-activities-201312136942#:~:text=We’ve%20known%20for%20some,of%20daily%20living%20without%20help.

6 Alexia Fernández Campbell, Home Health Aides for the Elderly: Who Will Care with Them? Vox (Aug. 21, 2019), https://www.vox.com/the-highlight/2019/8/21/20694768/home-health-aides-elder-care.

7 Daniel Costa, Temporary Migrant Workers or Immigrants, 6 Russell Sage Found. J. of the Soc. Sci. (2020), https://muse.jhu.edu/article/777518.

8 Wei-Duan Porter et al., Interventions to Prevent or Delay Long-Term Nursing Home Placements for Adults with Impairments: A Systematic Review of Reviews, 35 J. Gen. Intern. Med. 2118 (2020) (an excellent summary of the “aging in place” literature).

9 Priya Chidambaram, Over 200,000 Residents and Staff in Long-Term Care Facilities Have Died from COVID-19, Kaiser Family Foundation (Feb. 2, 2022), https://www.kff.org/policy-watch/over-200000-residents-and-staff-in-long-term-care-facilities-have-died-from-covid-19/#:~:text=Long%2DTerm%20Care%20Facility%20Residents,of%201%2F30%2F2022.

10 Jeanne Batalova, Immigrant Health-Care Workers in the United States, Migration Policy Institute (Apr. 7, 2023), https://www.migrationpolicy.org/article/immigrant-health-care-workers-united-states-2021 (the percentage representation of Caribbean people among home healthcare aides would be expected to be higher in both New York and Florida, which are the two highest receiving states for Caribbean migrants. The same report notes that New York and Florida have the highest proportion of home healthcare aides who are immigrants).

11 Mehgan Gallagher, The Truth behind Home Health Aid Certifications, O’Neil Institute for National & Global Health Law: Georgetown Law (Feb. 15, 2018), https://oneill.law.georgetown.edu/the-truth-behind-home-health-aide-certification-requirements (“there is no formal education requirement … to secure a position as an HHA”).

12 Lacey Loomer et al., Association between Nursing Home Staff Turnover and Infection Control Citations, 57 Health Serv. Res. 322 (2022) (a good summary of the literature on the connection between nursing home staff turnover and infection control).

13 Jonathan Weisman & Nicholas Fandos, G.O.P. Gets the Democratic Border Crisis It Wanted, N.Y. Times (Sep. 8, 2023), https://www.nytimes.com/2023/09/08/us/politics/gop-migrants-blue-cities.html.

14 Cristina Rodriguez, The Citizenship Paradox in a Transnational Age, 106 Mich. L. Rev. 1111 (2008).

16 Science Fiction, Legal Fiction, Political Fiction, and the 100-Year Life

1 Lynda Gratton & Andrew Scott, The 100-Year Life: Living and Working in an Age of Longevity 2 (2016).

2 Science Fiction, Oxford English Dictionary Online, https://www.oed.com/dictionary/science-fiction_n?tab=meaning_and_use#23960648 (accessed Nov. 27, 2023).

3 William Blackstone, Commentaries on the Laws of England 28 (Thomas P. Gallanis ed., 2016).

4 Mortality rate and life expectancy data come from the Human Mortality Database, https://mortality.org (accessed July 17, 2023).

5 Gratton and Scott cite the Human Mortality Database for their cohort median estimates, see Gratton & Scott, supra Footnote note 1, at 24 fig. 1.1, but that database does not include cohort median projections for post-1990 cohorts. Gratton and Scott’s numbers align precisely with estimates in another paper – Kaare Christensen, Gabriele Doblhammer, Roland Rau & James W. Vaupel, Ageing Populations: The Challenges Ahead, 374 Lancet 1196, 1197 tbl.1 (2009) – and Gratton and Scott cite Vaupel’s work elsewhere. See Gratton & Scott, supra Footnote note 1, at 377.

6 Author’s correspondence with Roland Rau.

7 S. Jay Olshansky, Bruce A. Carnes & Christine Cassel, In Search of Methuselah: Estimating the Upper Limits to Human Longevity, 250 Science 634, 634 (1990).

8 Elizabeth Arias, Melonie Heron & Betzaida Tejada-Vera, United States Life Tables Eliminating Certain Causes of Death, 1999–2001, 61 Nat’l Vital Statistics Report, 1, 101–104 tbl. 22 (2013).

9 Rafael de Cabo & Mark P. Mattson, Effects of Intermittent Fasting on Health, Aging, and Disease, 381 New Eng. J. Med. 2541, 2548 (2019).

10 See In re Zunshine, 816 Fed. App’x 477 (Fed. Cir. 2020) (affirming Patent and Trademark Office’s rejection of patent application for method of calorie restriction).

11 C. A. Bannister et al., Can People with Type 2 Diabetes Live Longer Than Those Without? A Comparison of Mortality in People Initiated with Metformin or Sulphonylurea Monotherapy and Matched, Non-Diabetic Controls, 16 Diabetes, Obesity & Metabolism 1165 (2014).

12 Megan Molteni, As Billionaires Race to Fund Anti-Aging Projects, a Much-Discussed Trial Goes Overlooked, STAT News (Aug. 9, 2022), https://www.statnews.com/2022/08/09/anti-aging-projects-funding-much-discussed-trial-overlooked.

13 Daniel J. Hemel & Lisa Larrimore Ouellette, The Generic Drug Trilemma, 2 Entrepreneurship & Innovation Policy & the Economy 41, 47–48 (2023).

14 Eric Budish, Benjamin N. Roin & Heidi Williams, Do Firms Underinvest in Long-Term Research? Evidence from Cancer Clinical Trials, 105 Am. Econ. Rev. 2044 (2015).

15 In re Estate of Buck, No. 23259 (Cal. Super. Ct. 1986), reprinted in 21 U.S.F. L. Rev. 691 (1987); see Douglas Bartholomew, The Battle for the Buck, L.A. Times (Dec. 21, 1986), https://www.latimes.com/archives/la-xpm-1986-12-21-tm-3738-story.html.

16 Tad Friend, Silicon Valley’s Quest to Live Forever, New Yorker (Mar. 27, 2017), https://www.newyorker.com/magazine/2017/04/03/silicon-valleys-quest-to-live-forever.

17 Research! America, U.S. Investments in Medical and Health Research and Development, 2016–2020 (2022), https://www.researchamerica.org/wp-content/uploads/2022/09/ResearchAmerica-Investment-Report.Final_.January-2022-1.pdf.

18 See Leonid Bershidsky, Google’s Main Business Could Use Some Moonshots, Bloomberg (May 8, 2021), https://www.bloomberg.com/opinion/articles/2021-05-08/google-s-other-bets-should-focus-on-its-main-business.

19 Julia Belluz, Google Is Super Secretive about Its Anti-Aging Research. No One Knows Why, Vox (Apr. 28, 2017), https://www.vox.com/science-and-health/2017/4/27/15409672/google-calico-secretive-aging-mortality-research.

20 US Dep’t Health and Human Services, Congressional Justification FY 2024 (2023), at 18–19, https://www.nia.nih.gov/sites/default/files/2023-03/nia_congressional-justification_fy2024.pdf.

21 Estimates of Funding for Various Research, Condition, and Disease Categories, Nat’l Institutes Health (Mar. 31, 2023), https://report.nih.gov/funding/categorical-spending#.

22 S. Jay Olshansky et al., The Longevity Dividend, The Scientist (Mar. 2006), https://www.the-scientist.com/uncategorized/the-longevity-dividend-47757; Bonnie Kavoussi, The Case for a Longevity Moonshot, Foundation for Am. Innovation (July 27, 2021), https://www.thefai.org/posts/the-case-for-a-longevity-moonshot.

23 Mancur Olson, The Logic of Collective Action (1965).

24 Dana P. Goldman et al., Substantial Health and Economic Returns from Delayed Aging May Warrant a New Focus for Medical Research, 32 Health Affs. 1698 (2013).

25 Sharayah Carter, Peter M. Clifton & Jennifer B. Keogh, Effect of Intermittent Compared with Continuous Energy Restricted Diet on Glycemic Control in Patients with Type 2 Diabetes: A Randomized Noninferiority Trial, 1 JAMA Network Open e180756 (2018).

26 J. L. Kirkland & T. Tchkonia, Senolytic Drugs: From Discovery to Translation, 288 J. Internal Med. 518 (2020).

17 Bioethics, Reproduction, and Extending Life

1 Norman Daniels, Just Health: Meeting Health Needs Fairly 149 (2008); Einer Elhauge, I’m Not Quite Dead Yet – and Other Health Care Observations, 49 Tulsa L. Rev. 607, 617 (2014).

2 I. Glenn Cohen, What (If Anything) Is Wrong with Human Enhancement? What (If Anything) Is Right with It? 49 Tulsa L. Rev. 645, 650 (2014).

3 Julian Baggini, Making Sense: Philosophy Behind the Headlines 181–182 (2002).

4 Frances M. Kamm, Is There a Problem with Enhancement? 5 Am. J. Bioethics 5, 8–9 (2005).

5 Cohen, supra Footnote note 2, at 651.

6 Elhauge, supra Footnote note 1, at 613.

7 E.g., Ctrs. for Medicare & Medicaid Servs., National Health Expenditure Data (updated Mar. 24, 2020), https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/NHE-Fact-Sheet.

8 The caveat of “healthcare spending” is essential because the all-things-considered level of positive or negative externalities is much more complicated to calculate and also more contested on what “counts.” For example, would effects on delayed entry to the job market for younger individuals because of people working longer count? Changes toward different numbers of offspring? What about additional years of grandparenthood and potential help in rearing?

9 Joel Feinberg, The Child’s Right to an Open Future, in Whose Child? Children’s Rights, Parental Authority, and State Power, 126, 130 (William Aiken & Hugh LaFollette eds., 1980).

10 See Cohen, supra Footnote note 2, 672–673; Dov Fox, The Illiberality of “Liberal Eugenics,” 20 Ratio 1, 20–21 (2007).

11 Cohen, supra Footnote note 2, at 672–673.

12 Footnote Id. at 658.

13 Footnote Id. at 659.

15 Michael J. Sandel, The Case against Perfection: Ethics in the Age of Genetic Engineering 87–92 (2007).

16 Nancy Kress, Beggars in Spain (1993).

17 Cohen, supra Footnote note 2, at 662–665; Kamm, supra Footnote note 4, at 13.

18 See Cohen, supra Footnote note 2, at 664 (arguing).

19 Cf. In Time (2011). Of course, given what we know about social determinants of health, it is entirely possible to view our current society as already structured along similar lines.

20 E.g., Alan Williams, Intergenerational Equity, an Exploration of the “Fair Innings” Argument, 6 Health Econ. 117 (1997); Samuel Kerstein & Greg Bognar, Complete Lives in the Balance, 10 Am. J. Bioethics 37 (2010).

21 Jonathan R. Macey, Private Trusts for the Provision of Private Goods, 37 Emory L.J. 295, 307 (1988).

22 Joshua Bote, A 74-Year-Old Woman Reportedly Gave Birth to Twins, May Be the Oldest Ever to Give Birth, USA Today (Sep. 6, 2019), https://www.usatoday.com/story/life/parenting/2019/09/06/oldest-woman-to-ever-give-birth-has-twins-at-74-years-old/2231598001/.

23 E.g., Judith Daar, I. Glenn Cohen, Seema Mohapatra & Sonia M. Suter, Reproductive Technologies and the Law 636 (3rd ed. 2022).

24 Maria Cramer, Girl Is Born in Tennessee from Embryo Frozen for 27 Years, N.Y. Times (Dec. 3, 2020).

26 Actor Doohan to Be Dad at 80, AP (Feb. 4, 2000), https://apnews.com/article/e427be362e2d89caca6e08dcab335d50.

27 Committee on the Ethical and Social Policy Considerations of Novel Techniques for Prevention of Maternal Transmission of Mitochondrial DNA Diseases, National Academies of Science, Engineering, and Medicine, Mitochondrial Replacement Techniques: Ethical, Social, and Policy Considerations 1 (Anne Claiborne et al. eds., 2016).

28 See I. Glenn Cohen, Eli Y. Adashi & Sara Gerke, The Regulation of Mitochondrial Replacement Techniques around the World, 21 Ann. Rev. Genomics & Hum. Gen. 565 (2020).

29 Cristina Rodríguez-Varela, Sonia Herraiz & Elena Labarta, Mitochondrial Enrichment in Infertile Patients: A Review of Different Mitochondrial Replacement Therapies, 15 Ther. Adv. Reprod. Health. (2021).

30 E.g., Mitinori Saitou & Katsuhiko Hayashi, Mammalian In Vitro Gametogenesis, 374 Science 47 (2021). For a discussion of its legal and ethical issues, see, e.g., Daar et al., supra Footnote note 23, at 1049–1100; Henry T. Greely, The End of Sex and the Future of Human Reproduction (2016).

31 See, e.g., Sonia M. Suter, In Vitro Gametogenesis: Just Another Way to Have a Baby? 3 J. L. & Biosci. 87, 99–100 (2016); Emily Witt, The Future of Fertility, New Yorker (Apr. 17, 2023) (discussing company seeking approval for clinical human use).

32 I. Glenn Cohen, Borrowed Wombs: On Uterus Transplants and the “Right to Experience Pregnancy,” 2022 U. Chi. L. F. 127, 134–135 (2023).

33 Footnote Id. at 136.

35 Footnote Id. at 137 (discussing Lisa C. Ikemoto, The In/Fertile, the Too Fertile, and the Dysfertile, 47 Hastings L.J. 1007, 1033 (1996)).

36 Cohen, supra Footnote note 32, at 138–139.

37 To be sure, in the US, at least as compared to a country like Israel, we have relatively little state-mandated support for even simple IVF.

38 Cohen, supra Footnote note 2, at 148–149.

39 Cf. Suter, supra Footnote note 31, at 99 (“If men can reproduce late into life, why should women be limited simply because biology precludes them from doing so at a younger age than men, particularly when men have a shorter life expectancy than women?”).

40 John N. Pomeroy, A Treatise on Equity Jurisprudence §§418–419 (5th ed. 1941).

41 See I. Glenn Cohen, Regulating Reproduction: The Problem with Best Interests, 96 Minn. L. Rev. 423, 451–452 (2011).

42 Alexander P. Frick, Advanced Maternal Age and Adverse Pregnancy Outcomes, 70 Best. Pract. Res. Clin. Obstet. Gynaecol. 92 (2021).

43 See Cohen, supra Footnote note 2, at 431.

44 Yu Gao, Yongfu Yu & Jingyuan Xiao, Association of Grandparental and Parental Age at Childbirth with Autism Spectrum Disorder in Children, 3 JAMA Network Open e202868 (2020). There is some evidence of transgenerational risk transmission based on studies of autism prevalence in grandchildren based on advanced grandparental age at the time of conceiving the grandchild’s parent. Footnote Id.

45 Derek Parfit, Reasons and Persons 358–359 (rev. ed. 1987). See also, e.g., John A. Robertson, Procreative Liberty and Harm to Offspring in Assisted Reproduction, 30 Am. J.L. & Med. 7 (2004).

46 Cohen, supra Footnote note 2, at 437–438.

47 See, e.g., I. Glenn Cohen, Sperm and Egg Donor Anonymity: Legal and Ethical Issues, in The Oxford Handbook of Reproductive Ethics, 499, 515–524 (Leslie Francis ed., 2015–2016); Helen M. Alvaré, A Response to Professor I. Glenn Cohen’s Regulating Reproduction: The Problem with Best Interests, 96 Minn. L. Rev. Headnotes 8 (2012); Kimberly M. Mutcherson, In Defense of Future Children: A Response to Cohen’s Beyond Best Interests, 96 Minn. L. Rev. Headnotes 46 (2012).

48 See generally Cohen, supra Footnote note 2; I. Glenn Cohen, Beyond Best Interests, 96 Minn. L. Rev. 1187 (2012).

49 See generally Cohen, supra Footnote note 48.

Accessibility standard: Unknown

Accessibility compliance for the HTML of this book is currently unknown and may be updated in the future.

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge-org.demo.remotlog.com is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×